QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) | ||||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading symbol(s) | Name of Each Exchange on Which Registered | ||||||||||||
NASDAQ Capital Market | ||||||||||||||
Large accelerated filer | ☐ | ☒ | ||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||||||||||
Emerging growth company |
Page | ||||||||
PART I - Financial Information | ||||||||
PART II - Other Information | ||||||||
March 31, 2021 | December 31, 2020 | |||||||||||||
ASSETS | (Unaudited) | (Audited) | ||||||||||||
Investments: | ||||||||||||||
Fixed maturities, available-for-sale, at fair value (amortized cost 2021 - $ | $ | $ | ||||||||||||
Equity securities, at fair value (cost 2021 - $ | ||||||||||||||
Equity method investments | ||||||||||||||
Other investments | ||||||||||||||
Total investments | ||||||||||||||
Cash and cash equivalents | ||||||||||||||
Restricted cash and cash equivalents | ||||||||||||||
Accrued investment income | ||||||||||||||
Reinsurance balances receivable, net | ||||||||||||||
Reinsurance recoverable on unpaid losses | ||||||||||||||
Loan to related party | ||||||||||||||
Deferred commission and other acquisition expenses (includes $ | ||||||||||||||
Funds withheld receivable (includes $ | ||||||||||||||
Other assets | ||||||||||||||
Total assets | $ | $ | ||||||||||||
LIABILITIES | ||||||||||||||
Reserve for loss and loss adjustment expenses (includes $ | $ | $ | ||||||||||||
Unearned premiums (includes $ | ||||||||||||||
Deferred gain on retroactive reinsurance | ||||||||||||||
Liability for securities purchased | ||||||||||||||
Accrued expenses and other liabilities (includes $ | ||||||||||||||
Senior notes - principal amount | ||||||||||||||
Less: unamortized debt issuance costs | ||||||||||||||
Senior notes, net | ||||||||||||||
Total liabilities | ||||||||||||||
Commitments and Contingencies | ||||||||||||||
EQUITY | ||||||||||||||
Preference shares | ||||||||||||||
Common shares ($ | ||||||||||||||
Additional paid-in capital | ||||||||||||||
Accumulated other comprehensive income | ||||||||||||||
Accumulated deficit | ( | ( | ||||||||||||
Treasury shares, at cost ( | ( | ( | ||||||||||||
Total shareholders’ equity | ||||||||||||||
Total liabilities and equity | $ | $ |
For the Three Months Ended March 31, | ||||||||||||||
2021 | 2020 | |||||||||||||
Revenues | ||||||||||||||
Gross premiums written | $ | ( | $ | |||||||||||
Net premiums written | $ | ( | $ | |||||||||||
Change in unearned premiums | ||||||||||||||
Net premiums earned | ||||||||||||||
Other insurance revenue | ||||||||||||||
Net investment income | ||||||||||||||
Net realized gains on investment | ||||||||||||||
Total other-than-temporary impairment losses | ( | |||||||||||||
Total revenues | ||||||||||||||
Expenses | ||||||||||||||
Net loss and loss adjustment expenses | ||||||||||||||
Commission and other acquisition expenses | ||||||||||||||
General and administrative expenses | ||||||||||||||
Interest and amortization expenses | ||||||||||||||
Foreign exchange and other gains | ( | ( | ||||||||||||
Total expenses | ||||||||||||||
Income before income taxes and interest in income of equity method investments | ||||||||||||||
Less: income tax expense | ||||||||||||||
Add: Interest in income of equity method investments | ||||||||||||||
Net income | ||||||||||||||
Gain from repurchase of preference shares | ||||||||||||||
Net income available to Maiden common shareholders | $ | $ | ||||||||||||
Basic and diluted earnings per share attributable to common shareholders | $ | $ | ||||||||||||
Weighted average number of common shares - basic | ||||||||||||||
Adjusted weighted average number of common shares and assumed conversions - diluted |
For the Three Months Ended March 31, | ||||||||||||||
2021 | 2020 | |||||||||||||
Net income | $ | $ | ||||||||||||
Other comprehensive loss | ||||||||||||||
Net unrealized holdings losses on fixed maturity investments arising during period | ( | ( | ||||||||||||
Net unrealized holdings losses on equity method investments arising during period | ( | |||||||||||||
Adjustment for reclassification of net realized gains recognized in net income | ( | ( | ||||||||||||
Foreign currency translation adjustment | ( | |||||||||||||
Other comprehensive loss, before tax | ( | ( | ||||||||||||
Income tax benefit related to components of other comprehensive loss | ||||||||||||||
Other comprehensive loss, after tax | ( | ( | ||||||||||||
Comprehensive loss | $ | ( | $ | ( | ||||||||||
For the Three Months Ended March 31, | ||||||||||||||
2021 | 2020 | |||||||||||||
Preference shares - Series A, C and D | ||||||||||||||
Beginning balance | $ | $ | ||||||||||||
Repurchase of Preference Shares – Series A | ( | — | ||||||||||||
Repurchase of Preference Shares – Series C | ( | — | ||||||||||||
Repurchase of Preference Shares – Series D | ( | — | ||||||||||||
Ending balance | ||||||||||||||
Common shares | ||||||||||||||
Beginning balance | ||||||||||||||
Exercise of options and issuance of common shares | ||||||||||||||
Ending balance | ||||||||||||||
Additional paid-in capital | ||||||||||||||
Beginning balance | ||||||||||||||
Exercise of options and issuance of common shares | ( | ( | ||||||||||||
Share-based compensation expense | ||||||||||||||
Repurchase of Preference Shares | — | |||||||||||||
Cash settlement of restricted shares granted | ( | — | ||||||||||||
Ending balance | ||||||||||||||
Accumulated other comprehensive income (loss) | ||||||||||||||
Beginning balance | ||||||||||||||
Change in net unrealized losses on investment | ( | ( | ||||||||||||
Foreign currency translation adjustment | ( | |||||||||||||
Ending balance | ( | |||||||||||||
Accumulated deficit | ||||||||||||||
Beginning balance | ( | ( | ||||||||||||
Cash settlement of restricted shares granted | ( | — | ||||||||||||
Net income | ||||||||||||||
Gain on repurchase of preference shares | — | |||||||||||||
Ending balance | ( | ( | ||||||||||||
Treasury shares | ||||||||||||||
Beginning balance | ( | ( | ||||||||||||
Shares repurchased | ( | |||||||||||||
Ending balance | ( | ( | ||||||||||||
Total shareholders' equity | $ | $ |
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||
Cash flows from operating activities | ||||||||||||||
Net income | $ | $ | ||||||||||||
Adjustments to reconcile net income to net cash flows from operating activities: | ||||||||||||||
Depreciation, amortization and share-based compensation | ||||||||||||||
Interest in income of equity method investments | ( | |||||||||||||
Net realized gains on investment | ( | ( | ||||||||||||
Total other-than-temporary impairment losses | ||||||||||||||
Foreign exchange and other gains | ( | ( | ||||||||||||
Changes in assets – (increase) decrease: | ||||||||||||||
Reinsurance balances receivable, net | ( | |||||||||||||
Reinsurance recoverable on unpaid losses | ||||||||||||||
Accrued investment income | ( | |||||||||||||
Deferred commission and other acquisition expenses | ||||||||||||||
Funds withheld receivable | ||||||||||||||
Other assets | ( | ( | ||||||||||||
Changes in liabilities – increase (decrease): | ||||||||||||||
Reserve for loss and loss adjustment expenses | ( | ( | ||||||||||||
Unearned premiums | ( | ( | ||||||||||||
Accrued expenses and other liabilities | ( | ( | ||||||||||||
Net cash used in operating activities | ( | ( | ||||||||||||
Cash flows from investing activities: | ||||||||||||||
Purchases of fixed maturities | ( | ( | ||||||||||||
Purchases of other investments | ( | ( | ||||||||||||
Purchases of equity method investments | ( | |||||||||||||
Proceeds from sales of fixed maturities | ||||||||||||||
Proceeds from maturities, paydowns and calls of fixed maturities | ||||||||||||||
Proceeds from sale and redemption of other investments | ||||||||||||||
Proceeds from sale and redemption of equity method investments | ||||||||||||||
Distributions from equity securities | ||||||||||||||
Others, net | ( | ( | ||||||||||||
Net cash provided by investing activities | ||||||||||||||
Cash flows from financing activities: | ||||||||||||||
Repurchase of common shares | ( | |||||||||||||
Repurchase of preference shares | ( | |||||||||||||
Cash settlement of restricted shares granted | ( | |||||||||||||
Net cash used in financing activities | ( | |||||||||||||
Effect of exchange rate changes on foreign currency cash, restricted cash and equivalents | ( | |||||||||||||
Net (decrease) increase in cash, restricted cash and cash equivalents | ( | |||||||||||||
Cash, restricted cash and cash equivalents, beginning of period | ||||||||||||||
Cash, restricted cash and cash equivalents, end of period | $ | $ | ||||||||||||
Reconciliation of cash and restricted cash reported within Condensed Consolidated Balance Sheets: | ||||||||||||||
Cash and cash equivalents, end of period | $ | $ | ||||||||||||
Restricted cash and cash equivalents, end of period | ||||||||||||||
Total cash, restricted cash and cash equivalents, end of period | $ | $ | ||||||||||||
For the Three Months Ended March 31, 2021 | Diversified Reinsurance | AmTrust Reinsurance | Total | |||||||||||||||||
Gross premiums written | $ | $ | ( | $ | ( | |||||||||||||||
Net premiums written | $ | ( | $ | ( | $ | ( | ||||||||||||||
Net premiums earned | $ | $ | $ | |||||||||||||||||
Other insurance revenue | ||||||||||||||||||||
Net loss and loss adjustment expenses ("loss and LAE") | ( | ( | ( | |||||||||||||||||
Commission and other acquisition expenses | ( | ( | ( | |||||||||||||||||
General and administrative expenses | ( | ( | ( | |||||||||||||||||
Underwriting (loss) income | $ | ( | $ | |||||||||||||||||
Reconciliation to net income | ||||||||||||||||||||
Net investment income and realized gains on investment | ||||||||||||||||||||
Interest and amortization expenses | ( | |||||||||||||||||||
Foreign exchange and other gains, net | ||||||||||||||||||||
Other general and administrative expenses | ( | |||||||||||||||||||
Income tax expense | ( | |||||||||||||||||||
Interest in income of equity method investments | ||||||||||||||||||||
Net income | $ | |||||||||||||||||||
Net loss and LAE ratio(1) | % | % | % | |||||||||||||||||
Commission and other acquisition expense ratio(2) | % | % | % | |||||||||||||||||
General and administrative expense ratio(3) | % | % | % | |||||||||||||||||
Expense ratio(4) | % | % | % | |||||||||||||||||
Combined ratio(5) | % | % | % |
For the Three Months Ended March 31, 2020 | Diversified Reinsurance | AmTrust Reinsurance | Total | |||||||||||||||||
Gross premiums written | $ | $ | $ | |||||||||||||||||
Net premiums written | $ | $ | $ | |||||||||||||||||
Net premiums earned | $ | $ | $ | |||||||||||||||||
Other insurance revenue | ||||||||||||||||||||
Net loss and LAE | ( | ( | ( | |||||||||||||||||
Commission and other acquisition expenses | ( | ( | ( | |||||||||||||||||
General and administrative expenses | ( | ( | ( | |||||||||||||||||
Underwriting loss | $ | ( | $ | ( | ( | |||||||||||||||
Reconciliation to net income | ||||||||||||||||||||
Net investment income and realized gains on investment | ||||||||||||||||||||
Total other-than-temporary impairment losses | ( | |||||||||||||||||||
Interest and amortization expenses | ( | |||||||||||||||||||
Foreign exchange and other gains, net | ||||||||||||||||||||
Other general and administrative expenses | ( | |||||||||||||||||||
Income tax expense | ( | |||||||||||||||||||
Net income | $ | |||||||||||||||||||
Net loss and LAE ratio(1) | % | % | % | |||||||||||||||||
Commission and other acquisition expense ratio(2) | % | % | % | |||||||||||||||||
General and administrative expense ratio(3) | % | % | % | |||||||||||||||||
Expense ratio(4) | % | % | % | |||||||||||||||||
Combined ratio(5) | % | % | % |
March 31, 2021 | Diversified Reinsurance | AmTrust Reinsurance | Total | |||||||||||||||||
Total assets - reportable segments | $ | $ | $ | |||||||||||||||||
Corporate assets | ||||||||||||||||||||
Total Assets | $ | $ | $ | |||||||||||||||||
December 31, 2020 | Diversified Reinsurance | AmTrust Reinsurance | Total | |||||||||||||||||
Total assets - reportable segments | $ | $ | $ | |||||||||||||||||
Corporate assets | ||||||||||||||||||||
Total Assets | $ | $ | $ |
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||||||||||||||
Net premiums written | Total | % of Total | Total | % of Total | ||||||||||||||||||||||
Diversified Reinsurance | ||||||||||||||||||||||||||
International | $ | ( | % | $ | % | |||||||||||||||||||||
Other | ( | % | % | |||||||||||||||||||||||
Total Diversified Reinsurance | ( | % | % | |||||||||||||||||||||||
AmTrust Reinsurance | ||||||||||||||||||||||||||
Small Commercial Business | ( | % | % | |||||||||||||||||||||||
Specialty Program | ( | % | % | |||||||||||||||||||||||
Specialty Risk and Extended Warranty | ( | % | % | |||||||||||||||||||||||
Total AmTrust Reinsurance | ( | % | % | |||||||||||||||||||||||
Total Net Premiums Written | $ | ( | % | $ | % | |||||||||||||||||||||
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||||||||||||||
Net premiums earned | Total | % of Total | Total | % of Total | ||||||||||||||||||||||
Diversified Reinsurance | ||||||||||||||||||||||||||
International | $ | % | $ | % | ||||||||||||||||||||||
Other | % | % | ||||||||||||||||||||||||
Total Diversified Reinsurance | % | % | ||||||||||||||||||||||||
AmTrust Reinsurance | ||||||||||||||||||||||||||
Small Commercial Business | ( | ( | % | % | ||||||||||||||||||||||
Specialty Program | ( | ( | % | % | ||||||||||||||||||||||
Specialty Risk and Extended Warranty | % | % | ||||||||||||||||||||||||
Total AmTrust Reinsurance | % | % | ||||||||||||||||||||||||
Total Net Premiums Earned | $ | % | $ | % | ||||||||||||||||||||||
March 31, 2021 | Original or amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value | ||||||||||||||||||||||
U.S. treasury bonds | $ | $ | $ | ( | $ | |||||||||||||||||||||
U.S. agency bonds – mortgage-backed | ( | |||||||||||||||||||||||||
Non-U.S. government bonds | ( | |||||||||||||||||||||||||
Asset-backed securities | ( | |||||||||||||||||||||||||
Corporate bonds | ( | |||||||||||||||||||||||||
Total fixed maturity investments | $ | $ | $ | ( | $ |
December 31, 2020 | Original or amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value | ||||||||||||||||||||||
U.S. treasury bonds | $ | $ | $ | $ | ||||||||||||||||||||||
U.S. agency bonds – mortgage-backed | ( | |||||||||||||||||||||||||
Non-U.S. government bonds | ||||||||||||||||||||||||||
Asset-backed securities | ( | |||||||||||||||||||||||||
Corporate bonds | ( | |||||||||||||||||||||||||
Total fixed maturity investments | $ | $ | $ | ( | $ |
March 31, 2021 | Amortized cost | Fair value | ||||||||||||
Due in one year or less | $ | $ | ||||||||||||
Due after one year through five years | ||||||||||||||
Due after five years through ten years | ||||||||||||||
Due after ten years | ||||||||||||||
U.S. agency bonds – mortgage-backed | ||||||||||||||
Asset-backed securities | ||||||||||||||
Total fixed maturity investments | $ | $ |
Less than 12 Months | 12 Months or More | Total | ||||||||||||||||||||||||||||||||||||
March 31, 2021 | Fair value | Unrealized losses | Fair value | Unrealized losses | Fair value | Unrealized losses | ||||||||||||||||||||||||||||||||
U.S. treasury bonds | $ | $ | ( | $ | $ | $ | $ | ( | ||||||||||||||||||||||||||||||
U.S. agency bonds – mortgage-backed | ( | ( | ||||||||||||||||||||||||||||||||||||
Non-U.S. government bonds | ( | ( | ||||||||||||||||||||||||||||||||||||
Asset-backed securities | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Corporate bonds | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Total temporarily impaired fixed maturities | $ | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||||
Less than 12 Months | 12 Months or More | Total | ||||||||||||||||||||||||||||||||||||
December 31, 2020 | Fair value | Unrealized losses | Fair value | Unrealized losses | Fair value | Unrealized losses | ||||||||||||||||||||||||||||||||
U.S. agency bonds – mortgage-backed | $ | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||||
Asset-backed securities | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Corporate bonds | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Total temporarily impaired fixed maturities | $ | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||||
March 31, 2021 | Amortized cost | Fair value | % of Total fair value | |||||||||||||||||
U.S. treasury bonds | $ | $ | % | |||||||||||||||||
U.S. agency bonds | % | |||||||||||||||||||
AAA | % | |||||||||||||||||||
AA+, AA, AA- | % | |||||||||||||||||||
A+, A, A- | % | |||||||||||||||||||
BBB+, BBB, BBB- | % | |||||||||||||||||||
BB+ or lower | % | |||||||||||||||||||
Total fixed maturities (1) | $ | $ | % |
December 31, 2020 | Amortized cost | Fair value | % of Total fair value | |||||||||||||||||
U.S. treasury bonds | $ | $ | % | |||||||||||||||||
U.S. agency bonds | % | |||||||||||||||||||
AAA | % | |||||||||||||||||||
AA+, AA, AA- | % | |||||||||||||||||||
A+, A, A- | % | |||||||||||||||||||
BBB+, BBB, BBB- | % | |||||||||||||||||||
BB+ or lower | % | |||||||||||||||||||
Total fixed maturities(1) | $ | $ | % |
March 31, 2021 | December 31, 2020 | |||||||||||||||||||||||||
Carrying value | % of Total | Carrying value | % of Total | |||||||||||||||||||||||
Private equity investments | $ | % | $ | % | ||||||||||||||||||||||
Private credit lending investments | % | % | ||||||||||||||||||||||||
Investment in limited partnerships | % | % | ||||||||||||||||||||||||
Other investments | % | % | ||||||||||||||||||||||||
Total other investments at fair value | % | % | ||||||||||||||||||||||||
Investments in direct lending entities (at cost) | % | % | ||||||||||||||||||||||||
Total other investments | $ | % | $ | % |
March 31, 2021 | December 31, 2020 | |||||||||||||||||||||||||
Fair Value | % of Total | Fair Value | % of Total | |||||||||||||||||||||||
Private equity investments | $ | % | $ | % | ||||||||||||||||||||||
Private credit lending investments | % | % | ||||||||||||||||||||||||
Investments in direct lending entities | % | % | ||||||||||||||||||||||||
Investment in limited partnerships | % | % | ||||||||||||||||||||||||
Total unfunded commitments on other investments | $ | % | $ | % |
March 31, 2021 | December 31, 2020 | |||||||||||||||||||||||||
Carrying Value | % of Total | Carrying Value | % of Total | |||||||||||||||||||||||
Hedge fund investments | $ | % | $ | % | ||||||||||||||||||||||
Investment in limited partnerships | % | % | ||||||||||||||||||||||||
Total equity method investments | $ | % | $ | % |
For the Three Months Ended March 31, | ||||||||||||||
2021 | 2020 | |||||||||||||
Fixed maturities | $ | $ | ||||||||||||
Income on funds withheld | ||||||||||||||
Interest income from loan to related party | ||||||||||||||
Cash and cash equivalents and other investments | ||||||||||||||
Investment expenses | ( | ( | ||||||||||||
Net investment income | $ | $ |
For the Three Months Ended March 31, 2021 | Gross gains | Gross losses | Net | |||||||||||||||||
Fixed maturities | $ | $ | ( | $ | ||||||||||||||||
Equity securities | ||||||||||||||||||||
Other investments | ( | |||||||||||||||||||
Net realized gains (losses) on investment | $ | $ | ( | $ | ||||||||||||||||
For the Three Months Ended March 31, 2020 | Gross gains | Gross losses | Net | |||||||||||||||||
Fixed maturities | $ | $ | ( | $ | ||||||||||||||||
Other investments | ||||||||||||||||||||
Net realized gains (losses) on investment | $ | $ | ( | $ | ||||||||||||||||
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||
Net gains recognized for equity securities during the period | $ | $ | ||||||||||||
Less: Net gains recognized for equity securities divested during the period | ( | |||||||||||||
Unrealized gains recognized for equity securities still held at reporting date | $ | $ |
March 31, 2021 | December 31, 2020 | |||||||||||||
Fixed maturities | $ | $ | ||||||||||||
Equity method investments | ( | |||||||||||||
Total net unrealized gains | ||||||||||||||
Deferred income tax | ( | ( | ||||||||||||
Net unrealized gains, net of deferred income tax | $ | $ | ||||||||||||
Change, net of deferred income tax | $ | ( | $ |
March 31, 2021 | December 31, 2020 | |||||||||||||
Restricted cash – third party agreements | $ | $ | ||||||||||||
Restricted cash – related party agreements | ||||||||||||||
Total restricted cash | ||||||||||||||
Restricted investments – in trust for third party agreements at fair value (amortized cost: 2021 – $ | ||||||||||||||
Restricted investments – in trust for related party agreements at fair value (amortized cost: 2021 – $ | ||||||||||||||
Restricted investments – liability for investments purchased for related party agreements | ||||||||||||||
Total restricted investments | ||||||||||||||
Total restricted cash and investments | $ | $ |
March 31, 2021 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Fair Value Based on NAV Practical Expedient | Total Fair Value | |||||||||||||||||||||||||||
Fixed maturities | ||||||||||||||||||||||||||||||||
U.S. treasury bonds | $ | $ | $ | $ | — | $ | ||||||||||||||||||||||||||
U.S. agency bonds – mortgage-backed | — | |||||||||||||||||||||||||||||||
Non-U.S. government bonds | — | |||||||||||||||||||||||||||||||
Asset-backed securities | — | |||||||||||||||||||||||||||||||
Corporate bonds | — | |||||||||||||||||||||||||||||||
Equity investments | — | |||||||||||||||||||||||||||||||
Other investments | ||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
As a percentage of total assets | % | % | % | % | % |
December 31, 2020 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Fair Value Based on NAV Practical Expedient | Total Fair Value | |||||||||||||||||||||||||||
Fixed maturities | ||||||||||||||||||||||||||||||||
U.S. treasury bonds | $ | $ | $ | $ | — | $ | ||||||||||||||||||||||||||
U.S. agency bonds – mortgage-backed | — | |||||||||||||||||||||||||||||||
Non-U.S. government bonds | — | |||||||||||||||||||||||||||||||
Asset-backed securities | — | |||||||||||||||||||||||||||||||
Corporate bonds | — | |||||||||||||||||||||||||||||||
Other investments | ||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
As a percentage of total assets | % | % | % | % | % |
Fair Value | Valuation Technique | Unobservable Inputs | Range | |||||||||||||||||||||||||||||
Private equity investments | $ | Quarterly financial statements | Estimated maturity dates | to | ||||||||||||||||||||||||||||
Other including start-ups | Recent market transactions | Liquidity discount rates | ||||||||||||||||||||||||||||||
Total Level 3 investments | $ |
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||
Balance - January 1 | $ | $ | ||||||||||||
Purchases | ||||||||||||||
Transfers out of Level 3 | ( | |||||||||||||
Total Level 3 investments - end of period | $ | $ |
March 31, 2021 | December 31, 2020 | |||||||||||||||||||||||||
Carrying Value | Fair Value | Carrying Value | Fair Value | |||||||||||||||||||||||
Senior Notes - MHLA – | $ | $ | $ | $ | ||||||||||||||||||||||
Senior Notes - MHNC – | ||||||||||||||||||||||||||
Total Senior Notes | $ | $ | $ | $ |
For the Three Months Ended March 31, 2021 | Change in net unrealized gains on investment | Foreign currency translation | Total | |||||||||||||||||
Beginning balance | $ | $ | ( | $ | ||||||||||||||||
Other comprehensive (loss) income before reclassifications | ( | ( | ||||||||||||||||||
Amounts reclassified from AOCI to net income, net of tax | ( | ( | ||||||||||||||||||
Net current period other comprehensive (loss) income | ( | ( | ||||||||||||||||||
Ending balance, Maiden shareholders | $ | $ | ( | $ | ||||||||||||||||
For the Three Months Ended March 31, 2020 | Change in net unrealized gains on investment | Foreign currency translation | Total | |||||||||||||||||
Beginning balance | $ | $ | ( | $ | ||||||||||||||||
Other comprehensive loss before reclassifications | ( | ( | ( | |||||||||||||||||
Amounts reclassified from AOCI to net loss, net of tax | ( | ( | ||||||||||||||||||
Net current period other comprehensive loss | ( | ( | ( | |||||||||||||||||
Ending balance, Maiden shareholders | $ | ( | $ | ( | $ | ( | ||||||||||||||
March 31, 2021 | 2016 Senior Notes | 2013 Senior Notes | Total | |||||||||||||||||
Principal amount | $ | $ | $ | |||||||||||||||||
Less: unamortized issuance costs | ||||||||||||||||||||
Carrying value | $ | $ | $ | |||||||||||||||||
December 31, 2020 | 2016 Senior Notes | 2013 Senior Notes | Total | |||||||||||||||||
Principal amount | $ | $ | $ | |||||||||||||||||
Less: unamortized issuance costs | ||||||||||||||||||||
Carrying value | $ | $ | $ | |||||||||||||||||
Other details: | ||||||||||||||||||||
Original debt issuance costs | $ | $ | ||||||||||||||||||
Maturity date | June 14, 2046 | December 1, 2043 | ||||||||||||||||||
Earliest redeemable date (for cash) | June 14, 2021 | December 1, 2018 | ||||||||||||||||||
Coupon rate | % | % | ||||||||||||||||||
Effective interest rate | % | % |
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||
Premiums written | ||||||||||||||
Direct | $ | $ | ||||||||||||
Assumed | ( | |||||||||||||
Ceded | ( | ( | ||||||||||||
Net | $ | ( | $ | |||||||||||
Premiums earned | ||||||||||||||
Direct | $ | $ | ||||||||||||
Assumed | ||||||||||||||
Ceded | ( | ( | ||||||||||||
Net | $ | $ | ||||||||||||
Loss and LAE | ||||||||||||||
Gross loss and LAE | $ | $ | ||||||||||||
Loss and LAE ceded | ( | |||||||||||||
Net | $ | $ |
March 31, 2021 | December 31, 2020 | |||||||||||||
Reserve for reported loss and LAE | $ | $ | ||||||||||||
Reserve for losses incurred but not reported ("IBNR") | ||||||||||||||
Reserve for loss and LAE | $ | $ |
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||
Gross loss and LAE reserves, January 1 | $ | $ | ||||||||||||
Less: reinsurance recoverable on unpaid losses, January 1 | ||||||||||||||
Net loss and LAE reserves, January 1 | ||||||||||||||
Net incurred losses related to: | ||||||||||||||
Current year | ||||||||||||||
Prior years | ( | ( | ||||||||||||
Net paid losses related to: | ||||||||||||||
Current year | ( | ( | ||||||||||||
Prior years | ( | ( | ||||||||||||
( | ( | |||||||||||||
Retroactive reinsurance adjustment | ||||||||||||||
Effect of foreign exchange rate movements | ( | ( | ||||||||||||
Net loss and LAE reserves, March 31 | ||||||||||||||
Reinsurance recoverable on unpaid losses, March 31 | ||||||||||||||
Gross loss and LAE reserves, March 31 | $ | $ |
For the Three Months Ended March 31, | ||||||||||||||
2021 | 2020 | |||||||||||||
Gross and net premiums written | $ | ( | $ | |||||||||||
Net premiums earned | ||||||||||||||
Net loss and LAE | ( | ( | ||||||||||||
Commission and other acquisition expenses | ( | ( |
March 31, 2021 | |||||
2021 | $ | ||||
2022 | |||||
2023 | |||||
2024 | |||||
Discount for present value | ( | ||||
Total discounted operating lease liabilities | $ |
For the Three Months Ended March 31, | ||||||||||||||
2021 | 2020 | |||||||||||||
Numerator: | ||||||||||||||
Net income | $ | $ | ||||||||||||
Gain from repurchase of preference shares - Series A, C and D | ||||||||||||||
Amount allocated to participating common shareholders(1) | ( | ( | ||||||||||||
Net income allocated to Maiden common shareholders | $ | $ | ||||||||||||
Denominator: | ||||||||||||||
Weighted average number of common shares – basic | ||||||||||||||
Potentially dilutive securities: | ||||||||||||||
Share options and restricted share units(2) | ||||||||||||||
Adjusted weighted average number of common shares – diluted(2) | ||||||||||||||
Basic and diluted earnings per share attributable to common shareholders | $ | $ | ||||||||||||
For the Three Months Ended March 31, | 2021 | 2020 | Change | |||||||||||||||||
Summary Consolidated Statement of Income Data (unaudited): | ($ in thousands except per share data) | |||||||||||||||||||
Net income | $ | 9,286 | $ | 20,861 | $ | (11,575) | ||||||||||||||
Gain from repurchase of preference shares | 62,450 | — | 62,450 | |||||||||||||||||
Net income attributable to Maiden common shareholders | 71,736 | 20,861 | 50,875 | |||||||||||||||||
Basic and diluted earnings per common share: | ||||||||||||||||||||
Net income attributable to common shareholders(2) | 0.83 | 0.25 | 0.58 | |||||||||||||||||
Gain from repurchase of preferred securities per common share | 0.73 | — | 0.73 | |||||||||||||||||
Gross premiums written | (2,390) | 11,734 | (14,124) | |||||||||||||||||
Net premiums earned | 11,764 | 31,215 | (19,451) | |||||||||||||||||
Underwriting income (loss)(3) | 1,555 | (3,693) | 5,248 | |||||||||||||||||
Net investment income | 9,841 | 17,964 | (8,123) | |||||||||||||||||
Combined ratio(4) | 185.3 | % | 131.6 | % | 53.7 | |||||||||||||||
Non-GAAP measures: | ||||||||||||||||||||
Non-GAAP operating earnings(1) | $ | 47,301 | $ | 3,132 | $ | 44,169 | ||||||||||||||
Non-GAAP basic and diluted operating earnings per common share(1) | 0.55 | 0.04 | 0.51 | |||||||||||||||||
Annualized non-GAAP operating return on average common shareholders' equity(1) | 81.4 | % | 8.7 | % | 72.7 | |||||||||||||||
March 31, 2021 | December 31, 2020 | Change | ||||||||||||||||||
Consolidated Financial Condition | ($ in thousands except per share data) | |||||||||||||||||||
Total investments and cash and cash equivalents(5) | $ | 1,227,967 | $ | 1,456,133 | $ | (228,166) | ||||||||||||||
Total assets | 2,702,562 | 2,948,455 | (245,893) | |||||||||||||||||
Reserve for loss and LAE | 1,784,508 | 1,893,299 | (108,791) | |||||||||||||||||
Senior notes - principal amount | 262,500 | 262,500 | — | |||||||||||||||||
Common shareholders' equity | 197,663 | 133,506 | 64,157 | |||||||||||||||||
Shareholders' equity | 426,611 | 527,816 | (101,205) | |||||||||||||||||
Total capital resources(6) | 689,111 | 790,316 | (101,205) | |||||||||||||||||
Ratio of debt to total capital resources(11) | 38.1 | % | 33.2 | % | 4.9 | |||||||||||||||
Book Value calculations: | ||||||||||||||||||||
Book value per common share(7) | $ | 2.29 | $ | 1.57 | $ | 0.72 | ||||||||||||||
Accumulated dividends per common share | 4.27 | 4.27 | — | |||||||||||||||||
Book value per common share plus accumulated dividends | $ | 6.56 | $ | 5.84 | $ | 0.72 | ||||||||||||||
Change in book value per common share plus accumulated dividends | 12.3 | % | ||||||||||||||||||
Diluted book value per common share(8) | $ | 2.28 | $ | 1.55 | $ | 0.73 | ||||||||||||||
Non-GAAP measures: | ||||||||||||||||||||
Adjusted book value per common share(9) | $ | 3.05 | $ | 2.46 | $ | 0.59 | ||||||||||||||
Adjusted Maiden shareholders' equity(10) | 491,707 | 602,757 | (111,050) | |||||||||||||||||
Adjusted total capital resources(10) | 754,207 | 865,257 | (111,050) | |||||||||||||||||
Ratio of debt to adjusted total capital resources(12) | 34.8 | % | 30.3 | % | 4.5 |
For the Three Months Ended March 31, | ||||||||||||||
($ in thousands) | 2021 | 2020 | ||||||||||||
Gross premiums written | $ | (2,390) | $ | 11,734 | ||||||||||
Net premiums written | $ | (2,696) | $ | 10,372 | ||||||||||
Net premiums earned | $ | 11,764 | $ | 31,215 | ||||||||||
Other insurance revenue | 269 | 408 | ||||||||||||
Net loss and LAE | (2,359) | (21,086) | ||||||||||||
Commission and other acquisition expenses | (5,942) | (11,973) | ||||||||||||
General and administrative expenses(1) | (2,177) | (2,257) | ||||||||||||
Underwriting income (loss)(2) | 1,555 | (3,693) | ||||||||||||
Other general and administrative expenses(1) | (11,820) | (6,293) | ||||||||||||
Net investment income | 9,841 | 17,964 | ||||||||||||
Net realized gains on investment | 8,101 | 11,038 | ||||||||||||
Total other-than-temporary impairment losses | — | (1,506) | ||||||||||||
Foreign exchange and other gains | 3,542 | 8,197 | ||||||||||||
Interest and amortization expenses | (4,831) | (4,831) | ||||||||||||
Income tax expense | (49) | (15) | ||||||||||||
Interest in income of equity method investments | 2,947 | — | ||||||||||||
Net income | 9,286 | 20,861 | ||||||||||||
Gain from repurchase of preference shares | 62,450 | — | ||||||||||||
Net income available to Maiden common shareholders | $ | 71,736 | $ | 20,861 | ||||||||||
Ratios | ||||||||||||||
Net loss and LAE ratio(3) | 19.6 | % | 66.7 | % | ||||||||||
Commission and other acquisition expense ratio(4) | 49.4 | % | 37.9 | % | ||||||||||
General and administrative expense ratio(5) | 116.3 | % | 27.0 | % | ||||||||||
Expense ratio(6) | 165.7 | % | 64.9 | % | ||||||||||
Combined ratio(7) | 185.3 | % | 131.6 | % |
For the Three Months Ended March 31, | 2021 | 2020 | Change in | |||||||||||||||||||||||
($ in thousands) | Total | Total | $ | % | ||||||||||||||||||||||
Diversified Reinsurance | $ | (234) | $ | 10,372 | $ | (10,606) | (102.3) | % | ||||||||||||||||||
AmTrust Reinsurance | (2,462) | — | (2,462) | NM | ||||||||||||||||||||||
Total | $ | (2,696) | $ | 10,372 | $ | (13,068) | (126.0) | % | ||||||||||||||||||
For the Three Months Ended March 31, | 2021 | 2020 | Change in | |||||||||||||||||||||||||||||||||||
($ in thousands) | Total | % of Total | Total | % of Total | $ | % | ||||||||||||||||||||||||||||||||
Diversified Reinsurance | $ | 6,240 | 53.1 | % | $ | 12,531 | 40.1 | % | $ | (6,291) | (50.2) | % | ||||||||||||||||||||||||||
AmTrust Quota Share Reinsurance | 5,524 | 46.9 | % | 18,684 | 59.9 | % | (13,160) | (70.4) | % | |||||||||||||||||||||||||||||
Total | $ | 11,764 | 100.0 | % | $ | 31,215 | 100.0 | % | $ | (19,451) | (62.3) | % | ||||||||||||||||||||||||||
For the Three Months Ended March 31, | ||||||||||||||
($ in thousands) | 2021 | 2020 | ||||||||||||
Average invested assets(1) | $ | 2,127,063 | $ | 2,705,803 | ||||||||||
Average book yield(2) | 1.9 | % | 2.7 | % | ||||||||||
For the Three Months Ended March 31, | ||||||||||||||
($ in thousands) | 2021 | 2020 | ||||||||||||
General and administrative expenses – segments | $ | 2,177 | $ | 2,257 | ||||||||||
General and administrative expenses – corporate | 11,820 | 6,293 | ||||||||||||
Total general and administrative expenses | $ | 13,997 | $ | 8,550 |
For the Three Months Ended March 31, | ||||||||||||||
($ in thousands) | 2021 | 2020 | ||||||||||||
Gross premiums written | $ | 72 | $ | 11,734 | ||||||||||
Net premiums written | $ | (234) | $ | 10,372 | ||||||||||
Net premiums earned | $ | 6,240 | $ | 12,531 | ||||||||||
Other insurance revenue | 269 | 408 | ||||||||||||
Net loss and LAE | (1,415) | (7,041) | ||||||||||||
Commission and other acquisition expenses | (3,755) | (4,979) | ||||||||||||
General and administrative expenses | (1,574) | (1,613) | ||||||||||||
Underwriting loss | $ | (235) | $ | (694) | ||||||||||
Ratios | ||||||||||||||
Net loss and LAE ratio | 21.7 | % | 54.4 | % | ||||||||||
Commission and other acquisition expense ratio | 57.7 | % | 38.5 | % | ||||||||||
General and administrative expense ratio | 24.2 | % | 12.5 | % | ||||||||||
Expense ratio | 81.9 | % | 51.0 | % | ||||||||||
Combined ratio | 103.6 | % | 105.4 | % |
For the Three Months Ended March 31, | 2021 | 2020 | Change in | |||||||||||||||||||||||
($ in thousands) | Total | Total | $ | % | ||||||||||||||||||||||
Net Premiums Written | ||||||||||||||||||||||||||
International | $ | (244) | $ | 10,372 | $ | (10,616) | (102.4) | % | ||||||||||||||||||
Other | 10 | — | 10 | NM | ||||||||||||||||||||||
Total Diversified Reinsurance | $ | (234) | $ | 10,372 | $ | (10,606) | (102.3) | % | ||||||||||||||||||
For the Three Months Ended March 31, | 2021 | 2020 | Change in | |||||||||||||||||||||||
($ in thousands) | Total | Total | $ | % | ||||||||||||||||||||||
Net Premiums Earned | ||||||||||||||||||||||||||
International | $ | 6,230 | $ | 12,531 | $ | (6,301) | (50.3) | % | ||||||||||||||||||
Other | 10 | — | 10 | NM | ||||||||||||||||||||||
Total Diversified Reinsurance | $ | 6,240 | $ | 12,531 | $ | (6,291) | (50.2) | % | ||||||||||||||||||
For the Three Months Ended March 31, | 2021 | 2020 | Change | |||||||||||||||||||||||
($ in thousands) | % | |||||||||||||||||||||||||
International | $ | 269 | $ | 353 | $ | (84) | (23.8) | % | ||||||||||||||||||
Other income | — | 55 | (55) | (100.0) | % | |||||||||||||||||||||
Total Diversified Reinsurance | $ | 269 | $ | 408 | $ | (139) | (34.1) | % | ||||||||||||||||||
For the Three Months Ended March 31, | ||||||||||||||
($ in thousands) | 2021 | 2020 | ||||||||||||
Gross premiums written | $ | (2,462) | $ | — | ||||||||||
Net premiums written | $ | (2,462) | $ | — | ||||||||||
Net premiums earned | $ | 5,524 | $ | 18,684 | ||||||||||
Net loss and LAE | (944) | (14,045) | ||||||||||||
Commission and other acquisition expenses | (2,187) | (6,994) | ||||||||||||
General and administrative expenses | (603) | (644) | ||||||||||||
Underwriting income (loss) | $ | 1,790 | $ | (2,999) | ||||||||||
Ratios | ||||||||||||||
Net loss and LAE ratio | 17.1 | % | 75.2 | % | ||||||||||
Commission and other acquisition expense ratio | 39.6 | % | 37.4 | % | ||||||||||
General and administrative expense ratio | 10.9 | % | 3.5 | % | ||||||||||
Expense ratio | 50.5 | % | 40.9 | % | ||||||||||
Combined ratio | 67.6 | % | 116.1 | % |
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||
($ in thousands) | Total | Total | ||||||||||||
Net Premiums Written | ||||||||||||||
Small Commercial Business | $ | (2,478) | $ | — | ||||||||||
Specialty Program | (25) | — | ||||||||||||
Specialty Risk and Extended Warranty | 41 | — | ||||||||||||
Total AmTrust Reinsurance | $ | (2,462) | $ | — | ||||||||||
For the Three Months Ended March 31, | 2021 | 2020 | Change in | |||||||||||||||||||||||||||||||||||
($ in thousands) | Total | % of Total | Total | % of Total | $ | % | ||||||||||||||||||||||||||||||||
Net Premiums Earned | ||||||||||||||||||||||||||||||||||||||
Small Commercial Business | $ | (2,351) | (42.6) | % | $ | 939 | 5.0 | % | $ | (3,290) | (350.4) | % | ||||||||||||||||||||||||||
Specialty Program | (18) | (0.3) | % | 75 | 0.4 | % | (93) | (124.0) | % | |||||||||||||||||||||||||||||
Specialty Risk and Extended Warranty | 7,893 | 142.9 | % | 17,670 | 94.6 | % | (9,777) | (55.3) | % | |||||||||||||||||||||||||||||
Total AmTrust Reinsurance | $ | 5,524 | 100.0 | % | $ | 18,684 | 100.0 | % | $ | (13,160) | (70.4) | % | ||||||||||||||||||||||||||
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||
($ in thousands) | ||||||||||||||
Operating activities | $ | (102,818) | $ | (218,481) | ||||||||||
Investing activities | 199,170 | 288,530 | ||||||||||||
Financing activities | (99,918) | — | ||||||||||||
Effect of exchange rate changes on foreign currency cash | (1,106) | 635 | ||||||||||||
Total (decrease) increase in cash, restricted cash and cash equivalents | $ | (4,672) | $ | 70,684 | ||||||||||
March 31, 2021 | December 31, 2020 | |||||||||||||
($ in thousands) | ||||||||||||||
Fixed maturities, available-for-sale, at fair value | $ | 976,897 | $ | 1,213,411 | ||||||||||
Equity securities, at fair value | 5,516 | — | ||||||||||||
Equity method investments | 40,183 | 39,886 | ||||||||||||
Other investments | 74,217 | 67,010 | ||||||||||||
Total investments | 1,096,813 | 1,320,307 | ||||||||||||
Cash and cash equivalents | 78,116 | 74,040 | ||||||||||||
Restricted cash and cash equivalents | 53,038 | 61,786 | ||||||||||||
Total Investments and Cash (including cash equivalents) | $ | 1,227,967 | $ | 1,456,133 |
March 31, 2021 | Original or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Average yield(1) | Average duration(2) | ||||||||||||||||||||||||||||||||
($ in thousands) | ||||||||||||||||||||||||||||||||||||||
U.S. treasury bonds | $ | 78,479 | $ | 13 | $ | (4) | $ | 78,488 | 0.1 | % | 1.4 | |||||||||||||||||||||||||||
U.S. agency bonds – mortgage-backed | 184,531 | 6,514 | (122) | 190,923 | 2.8 | % | 3.2 | |||||||||||||||||||||||||||||||
Non-U.S. government bonds | 7,256 | 605 | (16) | 7,845 | 1.0 | % | 6.3 | |||||||||||||||||||||||||||||||
Asset-backed securities | 176,982 | 1,424 | (120) | 178,286 | 2.2 | % | 0.7 | |||||||||||||||||||||||||||||||
Corporate bonds | 503,938 | 23,532 | (6,115) | 521,355 | 2.1 | % | 3.2 | |||||||||||||||||||||||||||||||
Total fixed maturities | 951,186 | 32,088 | (6,377) | 976,897 | 2.1 | % | 2.6 | |||||||||||||||||||||||||||||||
Cash and cash equivalents | 131,154 | — | — | $ | 131,154 | — | % | 0.0 | ||||||||||||||||||||||||||||||
Total | $ | 1,082,340 | $ | 32,088 | $ | (6,377) | $ | 1,108,051 | 1.8 | % | 2.3 |
December 31, 2020 | Original or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Average yield(1) | Average duration(2) | ||||||||||||||||||||||||||||||||
($ in thousands) | ||||||||||||||||||||||||||||||||||||||
U.S. treasury bonds | $ | 94,468 | $ | 34 | $ | — | $ | 94,502 | 0.1 | % | 1.4 | |||||||||||||||||||||||||||
U.S. agency bonds – mortgage-backed | 272,124 | 9,439 | (126) | 281,437 | 2.5 | % | 1.9 | |||||||||||||||||||||||||||||||
Non-U.S. government bonds | 8,641 | 1,067 | — | 9,708 | 1.1 | % | 6.2 | |||||||||||||||||||||||||||||||
Asset-backed securities | 184,227 | 1,611 | (406) | 185,432 | 2.2 | % | 0.7 | |||||||||||||||||||||||||||||||
Corporate bonds | 604,463 | 40,904 | (3,035) | 642,332 | 2.3 | % | 3.1 | |||||||||||||||||||||||||||||||
Total fixed maturities | 1,163,923 | 53,055 | (3,567) | 1,213,411 | 2.2 | % | 2.3 | |||||||||||||||||||||||||||||||
Cash and cash equivalents | 135,826 | — | — | 135,826 | 0.1 | % | 0.0 | |||||||||||||||||||||||||||||||
Total | $ | 1,299,749 | $ | 53,055 | $ | (3,567) | $ | 1,349,237 | 2.0 | % | 2.1 |
March 31, 2021 | December 31, 2020 | |||||||||||||
Fixed maturities and cash and cash equivalents | 2.3 | 2.1 | ||||||||||||
Reserve for loss and LAE(1) | 3.9 | 3.9 |
March 31, 2021 | December 31, 2020 | |||||||||||||||||||||||||
($ in thousands) | Fair Value | % of Total | Fair Value | % of Total | ||||||||||||||||||||||
GNMA – fixed rate | $ | — | — | % | $ | 17,385 | 6.2 | % | ||||||||||||||||||
GNMA – variable rate | 4,882 | 2.5 | % | 5,409 | 1.9 | % | ||||||||||||||||||||
FNMA – fixed rate | 91,968 | 48.2 | % | 119,910 | 42.6 | % | ||||||||||||||||||||
FHLMC – fixed rate | 94,073 | 49.3 | % | 138,733 | 49.3 | % | ||||||||||||||||||||
Total U.S. agency bonds | $ | 190,923 | 100.0 | % | $ | 281,437 | 100.0 | % |
Ratings(1) | ||||||||||||||||||||||||||||||||||||||
March 31, 2021 | AAA, AA+, AA, AA- | A+, A, A- | BBB+, BBB, BBB- | BB+ or lower | Fair Value | % of Corporate bonds portfolio | ||||||||||||||||||||||||||||||||
Corporate bonds | ($ in thousands) | |||||||||||||||||||||||||||||||||||||
Basic Materials | — | % | 1.2 | % | 0.8 | % | — | % | $ | 10,337 | 2.0 | % | ||||||||||||||||||||||||||
Communications | — | % | 1.1 | % | 3.4 | % | — | % | 23,679 | 4.5 | % | |||||||||||||||||||||||||||
Consumer | — | % | 2.4 | % | 22.9 | % | 2.2 | % | 143,406 | 27.5 | % | |||||||||||||||||||||||||||
Energy | — | % | 10.1 | % | 3.6 | % | 2.7 | % | 85,295 | 16.4 | % | |||||||||||||||||||||||||||
Financial Institutions | 7.4 | % | 22.0 | % | 12.7 | % | 1.2 | % | 225,952 | 43.3 | % | |||||||||||||||||||||||||||
Industrials | — | % | 1.1 | % | 0.7 | % | 1.0 | % | 14,189 | 2.8 | % | |||||||||||||||||||||||||||
Technology | — | % | 2.8 | % | 0.7 | % | — | % | 18,497 | 3.5 | % | |||||||||||||||||||||||||||
Total | 7.4 | % | 40.7 | % | 44.8 | % | 7.1 | % | $ | 521,355 | 100.0 | % |
Ratings(1) | ||||||||||||||||||||||||||||||||||||||
December 31, 2020 | AAA, AA+, AA, AA- | A+, A, A- | BBB+, BBB, BBB- | BB+ or lower | Fair Value | % of Corporate bonds portfolio | ||||||||||||||||||||||||||||||||
Corporate bonds | ($ in thousands) | |||||||||||||||||||||||||||||||||||||
Basic Materials | — | % | 1.0 | % | 1.4 | % | — | % | $ | 15,637 | 2.4 | % | ||||||||||||||||||||||||||
Communications | — | % | 1.0 | % | 4.6 | % | 1.6 | % | 46,167 | 7.2 | % | |||||||||||||||||||||||||||
Consumer | — | % | 2.0 | % | 21.7 | % | 1.8 | % | 164,033 | 25.5 | % | |||||||||||||||||||||||||||
Energy | 2.5 | % | 6.3 | % | 3.0 | % | 2.2 | % | 89,984 | 14.0 | % | |||||||||||||||||||||||||||
Financial Institutions | 7.2 | % | 23.8 | % | 13.0 | % | 1.0 | % | 288,649 | 45.0 | % | |||||||||||||||||||||||||||
Industrials | — | % | 0.9 | % | 1.2 | % | 0.8 | % | 18,494 | 2.9 | % | |||||||||||||||||||||||||||
Technology | — | % | 2.4 | % | 0.6 | % | — | % | 19,368 | 3.0 | % | |||||||||||||||||||||||||||
Total | 9.7 | % | 37.4 | % | 45.5 | % | 7.4 | % | $ | 642,332 | 100.0 | % |
March 31, 2021 | Fair Value | % of Holdings | Rating(1) | |||||||||||||||||
($ in thousands) | ||||||||||||||||||||
Electricite de France, 4.625%, Due 9/11/2024 | $ | 17,573 | 1.8 | % | A- | |||||||||||||||
Brookfield Asset Management Inc., 4.00% Due 1/15/2025 | 13,106 | 1.3 | % | A- | ||||||||||||||||
Nordea Bank ABP, 0.875% Due 6/26/2023 | 13,092 | 1.3 | % | A | ||||||||||||||||
Deutsche Bank AG, 1.25%, Due 9/8/2021 | 12,979 | 1.3 | % | BBB- | ||||||||||||||||
Bayer US Finance LLC, 3.375% Due 10/8/2024 | 12,925 | 1.3 | % | BBB+ | ||||||||||||||||
Anheuser-Busch INBEV NV, 2.875% Due 9/25/2024 | 12,921 | 1.3 | % | BBB+ | ||||||||||||||||
Carlsberg Breweries A/S, 2.5%, Due 5/28/2024 | 12,625 | 1.3 | % | BBB | ||||||||||||||||
Deutsche Bank AG (NY Branch), 3.7%, Due 5/30/2024 | 11,762 | 1.2 | % | BBB- | ||||||||||||||||
Total Capital International SA, 3.75%, Due 4/10/2024 | 10,962 | 1.1 | % | A+ | ||||||||||||||||
Thompson Reuters Corp, 4.3% Due 11/23/23 | 10,796 | 1.1 | % | BBB | ||||||||||||||||
Total | $ | 128,741 | 13.2 | % |
March 31, 2021 | December 31, 2020 | |||||||||||||||||||||||||
($ in thousands) | Fair Value | % of Total | Fair Value | % of Total | ||||||||||||||||||||||
Non-U.S. dollar denominated corporate bonds | $ | 331,852 | 97.7 | % | $ | 349,231 | 97.3 | % | ||||||||||||||||||
Non-U.S. government bonds | 7,845 | 2.3 | % | 9,708 | 2.7 | % | ||||||||||||||||||||
Total non-U.S. dollar denominated securities | $ | 339,697 | 100.0 | % | $ | 358,939 | 100.0 | % |
March 31, 2021 | December 31, 2020 | |||||||||||||||||||||||||
($ in thousands) | Fair Value | % of Total | Fair Value | % of Total | ||||||||||||||||||||||
Euro | $ | 314,401 | 92.5 | % | $ | 329,447 | 91.8 | % | ||||||||||||||||||
British Pound | 20,237 | 6.0 | % | 22,861 | 6.4 | % | ||||||||||||||||||||
Canadian Dollar | 5,059 | 1.5 | % | 5,110 | 1.4 | % | ||||||||||||||||||||
All other currencies | — | — | % | 1,521 | 0.4 | % | ||||||||||||||||||||
Total non-U.S. dollar denominated securities | $ | 339,697 | 100.0 | % | $ | 358,939 | 100.0 | % |
Ratings(1) | March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||||
($ in thousands) | Fair Value | % of Total | Fair Value | % of Total | ||||||||||||||||||||||
AAA | $ | 476 | 0.1 | % | $ | 1,277 | 0.4 | % | ||||||||||||||||||
AA+, AA, AA- | 26,334 | 7.9 | % | 31,102 | 8.9 | % | ||||||||||||||||||||
A+, A, A- | 160,668 | 48.4 | % | 165,585 | 47.4 | % | ||||||||||||||||||||
BBB+, BBB, BBB- | 130,847 | 39.5 | % | 137,297 | 39.3 | % | ||||||||||||||||||||
BB+ or lower | 13,527 | 4.1 | % | 13,970 | 4.0 | % | ||||||||||||||||||||
Total non-U.S. dollar denominated corporate bonds | $ | 331,852 | 100.0 | % | $ | 349,231 | 100.0 | % |
($ in thousands) | March 31, 2021 | December 31, 2020 | Change | Change % | ||||||||||||||||||||||
Reinsurance recoverable on unpaid losses | $ | 580,709 | $ | 592,571 | $ | (11,862) | (2.0) | % | ||||||||||||||||||
Deferred commission and other acquisition expenses | 46,852 | 51,903 | (5,051) | (9.7) | % | |||||||||||||||||||||
Other assets | 18,462 | 8,051 | 10,411 | 129.3 | % | |||||||||||||||||||||
Reserve for loss and LAE | 1,784,508 | 1,893,299 | (108,791) | (5.7) | % | |||||||||||||||||||||
Unearned premiums | 128,837 | 144,271 | (15,434) | (10.7) | % | |||||||||||||||||||||
Deferred gain on retroactive reinsurance | 65,096 | 74,941 | (9,845) | (13.1) | % | |||||||||||||||||||||
Accrued expenses and other liabilities | 41,220 | 53,002 | (11,782) | (22.2) | % |
($ in thousands) | March 31, 2021 | December 31, 2020 | Change | Change % | ||||||||||||||||||||||
Preference shares | $ | 228,948 | $ | 394,310 | $ | (165,362) | (41.9) | % | ||||||||||||||||||
Common shareholders' equity | 197,663 | 133,506 | 64,157 | 48.1 | % | |||||||||||||||||||||
Total shareholders' equity | 426,611 | 527,816 | (101,205) | (19.2) | % | |||||||||||||||||||||
Senior Notes - principal amount | 262,500 | 262,500 | — | — | % | |||||||||||||||||||||
Total capital resources | $ | 689,111 | $ | 790,316 | $ | (101,205) | (12.8) | % |
($ in thousands except share and per share data) | March 31, 2021 | December 31, 2020 | ||||||||||||
Ending common shareholders’ equity | $ | 197,663 | $ | 133,506 | ||||||||||
Proceeds from assumed conversion of dilutive options | 10 | 10 | ||||||||||||
Numerator for diluted book value per common share calculation | $ | 197,673 | $ | 133,516 | ||||||||||
Common shares outstanding | 86,141,057 | 84,801,161 | ||||||||||||
Shares issued from assumed conversion of dilutive options and restricted shares | 617,664 | 1,489,064 | ||||||||||||
Denominator for diluted book value per common share calculation | 86,758,721 | 86,290,225 | ||||||||||||
Book value per common share | $ | 2.29 | $ | 1.57 | ||||||||||
Diluted book value per common share | 2.28 | 1.55 |
($ in thousands) | March 31, 2021 | December 31, 2020 | ||||||||||||
Senior notes - principal amount | $ | 262,500 | $ | 262,500 | ||||||||||
Maiden shareholders’ equity | 426,611 | 527,816 | ||||||||||||
Total capital resources | $ | 689,111 | $ | 790,316 | ||||||||||
Ratio of debt to total capital resources | 38.1 | % | 33.2 | % |
For the Three Months Ended March 31, | 2021 | 2020 | ||||||||||||
($ in thousands except per share data) | ||||||||||||||
Net income available to Maiden common shareholders | $ | 71,736 | $ | 20,861 | ||||||||||
Add (subtract): | ||||||||||||||
Net realized gains on investment | (8,101) | (11,038) | ||||||||||||
Total other-than-temporary impairment losses | — | 1,506 | ||||||||||||
Foreign exchange and other gains | (3,542) | (8,197) | ||||||||||||
Interest in income of equity method investments | (2,947) | — | ||||||||||||
Favorable prior year loss development subject to LPT/ADC Agreement | (9,845) | — | ||||||||||||
Non-GAAP operating earnings | $ | 47,301 | $ | 3,132 | ||||||||||
Diluted earnings per share attributable to common shareholders | $ | 0.83 | $ | 0.25 | ||||||||||
Add (subtract): | ||||||||||||||
Net realized gains on investment | (0.09) | (0.13) | ||||||||||||
Total other-than-temporary impairment losses | — | 0.02 | ||||||||||||
Foreign exchange and other gains | (0.04) | (0.10) | ||||||||||||
Interest in income of equity method investments | (0.03) | — | ||||||||||||
Favorable prior year loss development subject to LPT/ADC Agreement | (0.12) | — | ||||||||||||
Non-GAAP diluted operating earnings per share available to common shareholders | $ | 0.55 | $ | 0.04 | ||||||||||
For the Three Months Ended March 31, | ||||||||||||||
($ in thousands) | 2021 | 2020 | ||||||||||||
Non-GAAP operating earnings | $ | 47,301 | $ | 3,132 | ||||||||||
Opening adjusted common shareholders’ equity | 208,447 | 155,668 | ||||||||||||
Ending adjusted common shareholders’ equity | 262,759 | 132,948 | ||||||||||||
Average adjusted common shareholders’ equity | 235,603 | 144,308 | ||||||||||||
Non-GAAP Operating ROACE | 81.4 | % | 8.7 | % |
For the Three Months Ended March 31, | ||||||||||||||
($ in thousands) | 2021 | 2020 | ||||||||||||
Gross premiums written | $ | (2,390) | $ | 11,734 | ||||||||||
Net premiums written | $ | (2,696) | $ | 10,372 | ||||||||||
Net premiums earned | $ | 11,764 | $ | 31,215 | ||||||||||
Other insurance revenue | 269 | 408 | ||||||||||||
Non-GAAP net loss and LAE(1) | (12,204) | (21,086) | ||||||||||||
Commission and other acquisition expenses | (5,942) | (11,973) | ||||||||||||
General and administrative expenses | (2,177) | (2,257) | ||||||||||||
Non-GAAP underwriting loss (1) | $ | (8,290) | $ | (3,693) | ||||||||||
Ratios: | ||||||||||||||
Non-GAAP net loss and LAE ratio(1) | 101.4 | % | 66.7 | % | ||||||||||
Commission and other acquisition expense ratio | 49.4 | % | 37.9 | % | ||||||||||
General and administrative expense ratio | 116.3 | % | 27.0 | % | ||||||||||
Expense ratio | 165.7 | % | 64.9 | % | ||||||||||
Non-GAAP combined ratio(1) | 267.1 | % | 131.6 | % |
For the Three Months Ended March 31, | ||||||||||||||
2021 | 2020 | |||||||||||||
Combined ratio | 185.3 | % | 131.6 | % | ||||||||||
Less: Favorable prior year loss development subject to LPT/ADC Agreement | (81.8) | % | — | % | ||||||||||
Non-GAAP combined ratio | 267.1 | % | 131.6 | % |
For the Three Months Ended March 31, | ||||||||||||||
($ in thousands) | 2021 | 2020 | ||||||||||||
Net loss and LAE | $ | 2,359 | $ | 21,086 | ||||||||||
Less: Favorable prior year loss development subject to LPT/ADC Agreement | (9,845) | — | ||||||||||||
Non-GAAP net loss and LAE | $ | 12,204 | $ | 21,086 |
($ in thousands) | March 31, 2021 | December 31, 2020 | Change | Change % | ||||||||||||||||||||||
Preference shares | $ | 228,948 | $ | 394,310 | $ | (165,362) | (41.9) | % | ||||||||||||||||||
Common shareholders' equity | 197,663 | 133,506 | 64,157 | 48.1 | % | |||||||||||||||||||||
Total shareholders' equity | 426,611 | 527,816 | (101,205) | (19.2) | % | |||||||||||||||||||||
Unamortized deferred gain on retroactive reinsurance | 65,096 | 74,941 | (9,845) | (13.1) | % | |||||||||||||||||||||
Adjusted shareholders' equity | 491,707 | 602,757 | (111,050) | (18.4) | % | |||||||||||||||||||||
Senior Notes - principal amount | 262,500 | 262,500 | — | — | % | |||||||||||||||||||||
Adjusted total capital resources | $ | 754,207 | $ | 865,257 | $ | (111,050) | (12.8) | % |
March 31, 2021 | December 31, 2020 | |||||||||||||
Book value per common share | $ | 2.29 | $ | 1.57 | ||||||||||
Unamortized deferred gain on retroactive reinsurance | 0.76 | 0.89 | ||||||||||||
Adjusted book value per common share | $ | 3.05 | $ | 2.46 |
($ in thousands) | March 31, 2021 | December 31, 2020 | ||||||||||||
Senior notes - principal amount | $ | 262,500 | $ | 262,500 | ||||||||||
Adjusted shareholders’ equity | 491,707 | 602,757 | ||||||||||||
Adjusted total capital resources | $ | 754,207 | $ | 865,257 | ||||||||||
Ratio of debt to adjusted total capital resources | 34.8 | % | 30.3 | % |
For the Three Months Ended March 31, 2021 | Total number of shares repurchased (a) | Average price paid per share | Total number of shares purchased as part of publicly announced plans or programs | Dollar amount still available under trading plan | ||||||||||||||||||||||
($ in thousands) | ||||||||||||||||||||||||||
January 1, 2021 - January 31, 2021 | — | $ | — | — | $ | 74,245 | ||||||||||||||||||||
February 1, 2021 - February 28, 2021 | — | — | — | 74,245 | ||||||||||||||||||||||
March 1, 2021 - March 31, 2021 | 799,548 | 2.95 | — | 74,245 | ||||||||||||||||||||||
Total | 799,548 | $ | 2.95 | — | 74,245 |
Name | Votes For | Withheld | Broker Non-Vote | |||||||||||||||||
Barry D. Zyskind | 38,876,474 | 247,775 | 27,529,988 | |||||||||||||||||
Holly L. Blanchard | 38,917,729 | 206,520 | 27,529,988 | |||||||||||||||||
Patrick J. Haveron | 38,801,251 | 322,998 | 27,529,988 | |||||||||||||||||
Simcha G. Lyons | 37,553,746 | 1,570,503 | 27,529,988 | |||||||||||||||||
Lawrence F. Metz | 38,901,555 | 222,694 | 27,529,988 | |||||||||||||||||
Raymond M. Neff | 38,881,391 | 242,858 | 27,529,988 | |||||||||||||||||
Yehuda L. Neuberger | 38,796,225 | 328,024 | 27,529,988 | |||||||||||||||||
Steven H. Nigro | 38,909,529 | 214,720 | 27,529,988 | |||||||||||||||||
Keith A. Thomas | 37,873,860 | 1,250,389 | 27,529,988 |
Votes For | Votes Against | Abstain | Broker Non-Vote | |||||||||||||||||
38,215,981 | 468,576 | 439,691 | 27,529,989 |
Votes For | Votes Against | Abstain | Broker Non-Vote | |||||||||||||||||
66,439,667 | 184,252 | 30,317 | — |
Exhibit No. | Description | |||||||
31.1 | ||||||||
31.2 | ||||||||
32.1 | ||||||||
32.2 | ||||||||
101.1 | The following materials from Maiden Holdings, Ltd. Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 formatted in Inline XBRL: (i) unaudited Condensed Consolidated Balance Sheets; (ii) unaudited Condensed Consolidated Statements of Income; (iii) unaudited Condensed Consolidated Statements of Comprehensive Income; (iv) unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity; (v) unaudited Condensed Consolidated Statements of Cash Flows; and (vi) Notes to unaudited Condensed Consolidated Financial Statements. |
MAIDEN HOLDINGS, LTD. | ||||||||
By: | ||||||||
May 10, 2021 | /s/ Lawrence F. Metz | |||||||
Lawrence F. Metz President and Co-Chief Executive Officer | ||||||||
/s/ Patrick J. Haveron | ||||||||
Patrick J. Haveron Co-Chief Executive Officer and Chief Financial Officer | ||||||||
1. | I have reviewed this quarterly report on Form 10-Q of Maiden Holdings, Ltd.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. |
(c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
May 10, 2021 | /s/ Lawrence F. Metz | ||||||||||
Lawrence F. Metz President and Co-Chief Executive Officer | |||||||||||
1. | I have reviewed this quarterly report on Form 10-Q of Maiden Holdings, Ltd.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. |
(c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
May 10, 2021 | /s/ Patrick J. Haveron | ||||||||||
Patrick J. Haveron Co-Chief Executive Officer and Chief Financial Officer | |||||||||||
May 10, 2021 | By: | /s/ Lawrence F. Metz | |||||||||
Lawrence F. Metz President and Co-Chief Executive Officer |
May 10, 2021 | By: | /s/ Patrick J. Haveron | |||||||||
Patrick J. Haveron Co-Chief Executive Officer and Chief Financial Officer |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 9,286 | $ 20,861 |
Other comprehensive loss | ||
Net unrealized holdings losses on fixed maturity investments arising during period | (19,531) | (40,203) |
Net unrealized holdings losses on equity method investments arising during period | (1,012) | 0 |
Adjustment for reclassification of net realized gains recognized in net income | (4,246) | (4,033) |
Foreign currency translation adjustment | 10,146 | (3) |
Other comprehensive loss, before tax | (14,643) | (44,239) |
Income tax benefit related to components of other comprehensive loss | 37 | 115 |
Other comprehensive loss, after tax | (14,606) | (44,124) |
Comprehensive income (loss) attributable to Maiden | $ (5,320) | $ (23,263) |
Basis of Presentation |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of Maiden Holdings, Ltd. ("Maiden Holdings") and its subsidiaries (the "Company" or "Maiden"). They have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X as promulgated by the U.S. Securities and Exchange Commission ("SEC"). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. All significant intercompany transactions and accounts have been eliminated. These interim unaudited Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim period and all such adjustments are of a normal recurring nature. The results of operations for the interim period are not necessarily indicative, if annualized, of those to be expected for the full year. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. These unaudited Condensed Consolidated Financial Statements, including these notes, should be read in conjunction with the Company's audited Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020. Certain prior year comparatives have been reclassified to conform to the current year presentation. The effect of these reclassifications had no impact on previously reported shareholders' equity or net income. As a result of a series of strategic actions the Company has taken in recent years as discussed below, we create shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets mostly in the insurance and related financial services industries where we can leverage our deep knowledge of those markets. We also provide a full range of legacy services to small insurance companies, particularly those in run-off or with blocks of reserves that are no longer core, working with clients to develop and implement finality solutions including acquiring entire companies. We expect our legacy solutions business to contribute to our active asset and capital management strategies. Short-term income protection business is written on a primary basis by our wholly owned subsidiaries Maiden Life Försäkrings AB ("Maiden LF") and Maiden General Försäkrings AB ("Maiden GF") in the Scandinavian and Northern European markets. Insurance support services are provided to Maiden LF and Maiden GF by our UK services company, Maiden Global Holdings Ltd. (“Maiden Global”) which is also a licensed intermediary in the United Kingdom. Maiden Global had previously operated internationally by providing branded auto and credit life insurance products through insurer partners, particularly those in the European Union ("EU") and other global markets. These products also produced reinsurance programs which were underwritten by our wholly owned subsidiary Maiden Reinsurance Ltd. (“Maiden Reinsurance”). The Company is not actively underwriting reinsurance business but has some historic reinsurance programs underwritten by Maiden Reinsurance which are in run-off. The Company continues to run-off the liabilities associated with AmTrust Financial Services, Inc. ("AmTrust") reinsurance agreements which were terminated in 2019 as discussed in "Note 10 - Related Party Transactions". We have a retroactive reinsurance agreement and a commutation agreement that further reduces our exposure to and limits the potential volatility related to these AmTrust liabilities, which are discussed in "Note 8 - Reinsurance". Since 2018, the Company has engaged in a series of strategic measures that have dramatically reduced the regulatory capital required to operate our business, materially strengthened our solvency ratios, re-domiciled Maiden Reinsurance from Bermuda to Vermont in the U.S. and ceased active reinsurance underwriting. These transactions can be found in Part II of our Annual Report on Form 10-K for the year ended December 31, 2020 that was filed with the SEC on March 15, 2021 and are more fully described (as applicable) in "Note 8 - Reinsurance" and "Note 10 - Related Party Transactions" in these financial statements. Please see the Company's audited Consolidated Financial Statements, and related notes thereto, included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 for further details on the above transactions. Re-domestication of Maiden Reinsurance Effective March 16, 2020, we re-domesticated our principal operating subsidiary, Maiden Reinsurance, from Bermuda to the State of Vermont in the U.S., having determined that re-domesticating Maiden Reinsurance to Vermont enables us to better align our capital and resources with our liabilities, which originate mostly in the United States, resulting in a more efficient structure. Maiden Reinsurance is now subject to the statutes and regulations of Vermont in the ordinary course of business. The re-domestication, in combination with other strategic measures described above that were completed in 2019, will continue to strengthen the Company’s capital position and solvency ratios. While the Vermont Department of Financial Regulation ("Vermont DFR") is now the group supervisor for the Company, the re-domestication did not apply to the parent holding company which remains a Bermuda-based holding company. Securities issued by Maiden Holdings were not affected by the re-domestication of Maiden Reinsurance to Vermont. Concurrent with its re-domestication to Vermont on March 16, 2020, Maiden Holdings contributed as capital the remaining 65% of its ownership in Maiden Reinsurance to Maiden Holdings North America, Ltd. ("Maiden NA"). Maiden NA now owns 100% of Maiden Reinsurance in the aggregate. 1. Basis of Presentation (continued) COVID-19 Pandemic The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, uncertain and rapidly evolving. Our results of operations, financial condition, and liquidity and capital resources may have been adversely impacted by the COVID-19 pandemic, and the future impact of the pandemic on our financial condition or results of operations is difficult to predict. As described herein, the Company is not presently engaged in active reinsurance underwriting and is running off the remaining unearned exposures it has reinsured. Maiden Global’s business development teams partner with automobile manufacturers, dealer associations and local primary insurers to design and implement point of sale insurance programs which generate revenue for the auto manufacturer and insurance premiums for the primary insurer ("IIS unit"). The Company's IIS unit does write limited primary insurance coverages that could be exposed to COVID-19 claims. While we assess our exposure to COVID-19 insurance and reinsurance claims on our existing insurance exposures and remaining reinsurance exposures as limited and immaterial, given the uncertainty surrounding the COVID-19 pandemic and its impact on the insurance industry, our preliminary estimates of losses and loss adjustment expenses and estimates of reinsurance recoverable arising from the COVID-19 pandemic may materially change. Maiden Reinsurance has not received any COVID-19 claims to date but our companies within our IIS unit have received a limited number of claims related to those coverages which it deems as immaterial. Unanticipated issues relating to claims and coverage may emerge, which could adversely affect our business by increasing the scope of coverage beyond our intent and/or increasing the frequency and severity of claims. The Company's investment portfolio may be adversely impacted by unfavorable market conditions caused by the COVID-19 pandemic, and the Company and its reinsurance subsidiaries may need additional capital to maintain compliance with regulatory capital requirements and/or be required to post additional collateral under existing reinsurance arrangements, which could reduce our liquidity. In addition, the Company may experience continued volatility in its results of operations which could negatively impact its financial condition and create a reduction in the amount of available distribution or dividend capacity from its regulated reinsurance subsidiaries, which would also reduce liquidity.
|
Significant Accounting Policies |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Significant Accounting Policies There have been no material changes to the significant accounting policies as described in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 except for the following: Recently Adopted Accounting Standards Updates No new accounting standards have been recently adopted for the three months ended March 31, 2021. Recently Issued Accounting Standards Not Yet Adopted Accounting for Measurement of Credit Losses on Financial Instruments In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13 "Financial Instruments: Credit Losses (Topic 326)" replacing the "incurred loss" impairment methodology with an approach based on "expected losses" to estimate credit losses on certain types of financial instruments and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance requires financial assets to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the cost of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. ASU 2016-13 also modified the accounting for available-for-sale ("AFS") debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments: Credit Losses Available-for-Sale Debt Securities. Credit losses relating to AFS debt securities will be recorded through an allowance for credit losses rather than under the current other-than-temporarily impaired ("OTTI") methodology. In April 2019, the FASB issued ASU 2019-04 for targeted improvements related to ASU 2016-13 which clarify that an entity should include all expected recoveries in its estimate of the allowance for credit losses. In addition, for collateral dependent financial assets, the amendments mandate that an allowance for credit losses that is added to the amortized cost basis of the financial asset should not exceed amounts previously written off. It also clarifies FASB’s intent to include all reinsurance recoverables within the scope of Topic 944 to be within the scope of Subtopic 326-20, regardless of the measurement basis of those recoverables. The Company's reinsurance recoverable on unpaid losses is currently the most significant financial asset within the scope of ASU 2016-13. The guidance is effective for public business entities, excluding entities eligible to be smaller reporting companies ("SRCs") as defined by the SEC, for annual periods beginning after December 15, 2019, and interim periods therein. The guidance is effective for all other entities, including public entities eligible to be SRCs, for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. As of March 31, 2021, the Company qualified for SRC status, as determined on the last business day of its most recent second quarter, and is thus eligible to follow the reporting deadlines and effective dates applicable to SRCs. Therefore Topic 326 will not be effective until the 2023 fiscal year. The Company continues to evaluate the impact of this guidance on its results of operations, financial condition and liquidity.
|
Segment Information |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | Segment Information The Company currently has two reportable segments: Diversified Reinsurance and AmTrust Reinsurance. Our Diversified Reinsurance segment consists of a portfolio of predominantly property and casualty reinsurance business focusing on regional and specialty property and casualty insurance companies located primarily in Europe. Our AmTrust Reinsurance segment includes all business ceded to Maiden Reinsurance by AmTrust, primarily the quota share reinsurance agreement (“AmTrust Quota Share”) between Maiden Reinsurance and AmTrust’s wholly owned subsidiary, AmTrust International Insurance, Ltd. (“AII”) and the European hospital liability quota share reinsurance contract ("European Hospital Liability Quota Share") with AmTrust’s wholly owned subsidiaries AmTrust Europe Limited ("AEL") and AmTrust International Underwriters DAC ("AIU DAC"), which are both in run-off effective January 1, 2019. Please refer to "Note 10. Related Party Transactions" for additional information regarding the AmTrust Reinsurance segment. The Company evaluates segment performance based on segment profit separately from the results of our investment portfolio. General and administrative expenses are allocated to the segments on an actual basis except salaries and benefits where management’s judgment is applied; however general corporate expenses are not allocated to the segments. In determining total assets by reportable segment, the Company identifies those assets that are attributable to a particular segment such as reinsurance balances receivable, reinsurance recoverable on unpaid losses, deferred commission and other acquisition expenses, funds withheld receivable, loan to related party and restricted cash and investments. All remaining assets are allocated to Corporate. The following tables summarize the underwriting results of our reportable segments and the reconciliation of our reportable segments' underwriting results to consolidated net income from operations:
3. Segment Information (continued)
(1)Calculated by dividing net loss and LAE by the sum of net premiums earned and other insurance revenue. (2)Calculated by dividing commission and other acquisition expenses by the sum of net premiums earned and other insurance revenue. (3)Calculated by dividing general and administrative expenses by the sum of net premiums earned and other insurance revenue. (4)Calculated by adding together the commission and other acquisition expense ratio and general and administrative expense ratio. (5)Calculated by adding together net loss and LAE ratio and the expense ratio. The following tables summarize the financial position of the Company's reportable segments including the reconciliation to the Company's consolidated total assets at March 31, 2021 and December 31, 2020:
3. Segment Information (continued) The following table sets forth financial information relating to net premiums written by major line of business and reportable segment for the three months ended March 31, 2021 and 2020:
The following table sets forth financial information relating to net premiums earned by major line of business and reportable segment for the three months ended March 31, 2021 and 2020:
|
Investments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments | Investments The Company holds: (i) AFS portfolios of fixed maturity and equity securities, carried at fair value; (ii) other investments, of which certain investments are carried at fair value and investments in direct lending entities are carried at cost less impairment; (iii) equity method investments; and (iv) funds held - directly managed. a)Fixed Maturities The amortized cost, gross unrealized gains and losses, and fair value of fixed maturities at March 31, 2021 and December 31, 2020 are as follows:
The contractual maturities of our fixed maturities are shown below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
The following tables summarize fixed maturities in an unrealized loss position and the aggregate fair value and gross unrealized loss by length of time the security has continuously been in an unrealized loss position:
4. Investments (continued) At March 31, 2021, there were 55 securities in an unrealized loss position with a fair value of $179,462 and unrealized losses of $6,377. Of these securities, there were 25 securities that have been in an unrealized loss position for twelve months or greater with a fair value of $83,956 and unrealized losses of $4,689.
At December 31, 2020, there were 53 securities in an unrealized loss position with a fair value of $166,564 and unrealized losses of $3,567. Of these securities, there were 35 securities that have been in an unrealized loss position for twelve months or greater with a fair value of $101,994 and unrealized losses of $2,375. Other-than-temporarily impaired The Company performs quarterly reviews of its fixed maturities in order to determine whether declines in fair value below the amortized cost basis were considered other-than-temporary in accordance with applicable guidance. At March 31, 2021, we determined that unrealized losses on fixed maturities were primarily due to changes in interest rates as well as the impact of foreign exchange rate changes on certain foreign currency denominated fixed maturities since their date of purchase. All fixed maturity securities continue to pay the expected coupon payments under the contractual terms of the securities. Any credit-related impairment related to fixed maturity securities that the Company does not plan to sell and for which the Company is not more likely than not to be required to sell is recognized in net earnings, with the non-credit related impairment recognized in comprehensive earnings. Based on the Company's analysis, our fixed maturity portfolio is of high credit quality and we believe the amortized cost basis of the securities will ultimately be recovered. The Company continually monitors the credit quality of the fixed maturity investments to assess if it is probable that it will receive contractual or estimated cash flows in the form of principal and interest. For the three months ended March 31, 2020, the Company recognized $1,506 in OTTI charges in earnings on two fixed maturity securities. There was no impairment recognized for the three months ended March 31, 2021. The following tables summarize the credit ratings of our fixed maturities as at March 31, 2021 and December 31, 2020:
(1)Ratings above are based on Standard & Poor’s ("S&P"), or equivalent, ratings. 4. Investments (continued) b)Other Investments and Equity Method Investments Other investments The table shows the composition of the Company's other investments as at March 31, 2021 and December 31, 2020:
The Company's investments in direct lending entities of $36,533 at March 31, 2021 (December 31, 2020 - $36,571) are carried at cost less impairment, if any, with any indication of impairment recognized in income when determined. Please see "Note 5(d) - Fair Value Measurements" for additional information regarding this investment. Certain of the Company's other investments are subject to restrictions on redemptions and sales that are determined by the governing documents, which limits our ability to liquidate those investments. These restrictions may include lock-ups, redemption gates, restricted share classes, restrictions on the frequency of redemption and notice periods. A gate is the ability to deny or delay a redemption request. Certain other investments may not have any restrictions governing their sale, but there is no active market and no guarantee that we will be able to execute a sale in a timely manner. In addition, even if certain other investments are not eligible for redemption or sales are restricted, the Company may still receive income distributions from those other investments. The Company's remaining unfunded commitments on other investments as at March 31, 2021 and December 31, 2020 were:
Equity Method Investments Certain of the Company's investments include an interest in variable interest entities which are not consolidated limited partnerships, as it has been determined that the Company is not the primary beneficiary. However, there is deemed to be limited influence over the operating and financial policies of the investee and accordingly these investments are reported under the equity method of accounting. In applying the equity method of accounting, the investments are initially recorded at cost and are subsequently adjusted based on the Company’s proportionate share of the investee's net income or loss. The maximum exposure to loss on these interests is limited to the amount of commitment made by the Company. The equity method investments include hedge funds and investments in limited partnerships such as direct lending funds, private equity funds and real estate funds. The table below shows the carrying value of the Company's equity method investments as at March 31, 2021 and December 31, 2020:
4. Investments (continued) c)Net Investment Income Net investment income was derived from the following sources for the three months ended March 31, 2021 and 2020:
d) Realized Gains (Losses) on Investment Realized gains or losses on the sale of investments are determined on the basis of the first in first out cost method. The following tables show the net realized gains (losses) on investment included in the Condensed Consolidated Statements of Income:
Realized gains and losses from equity securities detailed in the table above include both sales of securities and unrealized gains and losses from fair value changes. The portion of unrealized gains recognized within net income for investments still held at the end of March 31, 2021 and 2020, respectively, were as follows:
Proceeds from sales of fixed maturities were $153,816 for the three months ended March 31, 2021 (2020 - $224,471). Net unrealized gains on investments was as follows at March 31, 2021 and December 31, 2020, respectively:
4. Investments (continued) e)Restricted Cash and Cash Equivalents and Investments The Company is required to provide collateral for its reinsurance liabilities under various reinsurance agreements and utilizes trust accounts to collateralize business with reinsurance counterparties. The assets in trust as collateral are primarily cash and highly rated fixed maturities. The fair values of these restricted assets were as follows at March 31, 2021 and December 31, 2020:
|
Fair Value of Financial Instruments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments | Fair Value of Financial Instruments (a) Fair Values of Financial Instruments Fair Value Measurements — Accounting Standards Codification Topic 820, "Fair Value Measurements and Disclosures" ("ASC 820") defines fair value as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between open market participants at the measurement date. Additionally, ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy is broken down into three levels based on the reliability of inputs: •Level 1 — Valuations based on unadjusted quoted market prices for identical assets or liabilities that we have the ability to access. Because valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Examples of assets and liabilities utilizing Level 1 inputs include: U.S. Treasury bonds; •Level 2 — Valuations based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in inactive markets, or valuations based on models where the significant inputs are observable (e.g. interest rates, yield curves, prepayment speeds, default rates, loss severity, etc.) or can be corroborated by observable market data. Examples of assets and liabilities utilizing Level 2 inputs include: U.S. government-sponsored agency securities; non-U.S. government and supranational obligations; commercial mortgage-backed securities ("CMBS"); collateralized loan obligations ("CLO"); corporate and municipal bonds; and •Level 3 — Valuations based on models where significant inputs are not observable. The unobservable inputs reflect our own assumptions about assumptions that market participants would use developed on the basis of the best information available in the particular circumstances. Examples of assets and liabilities utilizing Level 3 inputs include: an investment in preference shares of a start-up insurance producer. The availability of observable inputs can vary and is affected by a wide variety of factors, including, for example, the type of financial instrument, whether the financial instrument is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires significantly more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in the Level 3 hierarchy. The Company uses prices and inputs that are current as at the measurement date. In periods of market dislocation, the observability of prices and inputs may be reduced for many instruments. This condition could cause an instrument to be reclassified between hierarchy levels. For investments that have quoted market prices in active markets, the Company uses the quoted market prices as fair value and includes these in the Level 1 hierarchy. The Company receives the quoted market prices from a third party nationally recognized provider ("the Pricing Service"). When quoted market prices are unavailable, the Company utilizes the Pricing Service to determine an estimate of fair value. The fair value estimates are included in the Level 2 hierarchy. The Company will challenge any prices for its investments which are considered not to be representative of fair value. 5. Fair Value Measurements (continued) If quoted market prices and an estimate from the Pricing Service are unavailable, the Company produces an estimate of fair value based on dealer quotations for recent activity in positions with the same or similar characteristics to that being valued. The Company determines whether the fair value estimate is in the Level 2 or Level 3 hierarchy depending on the level of observable inputs available when estimating the fair value. The Company bases its estimates of fair values for assets on the bid price as it represents what a third party market participant would be willing to pay in an orderly transaction. ASC 825, "Disclosure About Fair Value of Financial Instruments", requires all entities to disclose the fair value of their financial instruments for assets and liabilities recognized and not recognized in the balance sheet, for which it is practicable to estimate fair value. The following describes the valuation techniques used by the Company to determine the fair value of financial instruments that are measured at fair value on a recurring basis held at March 31, 2021 and December 31, 2020. U.S. government and U.S. agency — Bonds issued by the U.S. Treasury, the Federal Home Loan Bank, the Federal Home Loan Mortgage Corporation, Government National Mortgage Association, Federal National Mortgage Association and the Federal Farm Credit Banks Funding Corporation. The fair values of U.S. treasury bonds are based on quoted market prices in active markets, and are included in the Level 1 fair value hierarchy. We believe the market for U.S. treasury bonds is an actively traded market given the high level of daily trading volume. The fair values of U.S. agency bonds are determined using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of U.S. agency bonds are included in the Level 2 fair value hierarchy. Non-U.S. government and supranational bonds — These securities are generally priced by independent pricing services. The Pricing Service may use current market trades for securities with similar quality, maturity and coupon. If no such trades are available, the Pricing Service typically uses analytical models which may incorporate spreads, interest rate data and market/sector news. As the significant inputs used to price non-U.S. government and supranational bonds are observable market inputs, the fair values of non-U.S. government and supranational bonds are included in the Level 2 fair value hierarchy. Asset-backed securities — These securities comprise commercial mortgage-backed securities ("CMBS") and collateralized loan obligations ("CLO") originated by a variety of financial institutions that on acquisition are rated BBB-/Baa3 or higher. These securities are priced by independent pricing services and brokers. The pricing provider applies dealer quotes and other available trade information, prepayment speeds, yield curves and credit spreads to the valuation. As the significant inputs used to price the CMBS and CLO are observable market inputs, their fair values are included in the Level 2 fair value hierarchy. Corporate and municipal bonds — Bonds issued by corporations, U.S. state and municipality entities or agencies that on acquisition are rated BBB-/Baa3 or higher. These securities are generally priced by independent pricing services. The credit spreads are sourced from broker/dealers, trade prices and new issue market. Where pricing is unavailable from pricing services, custodian pricing or non-binding quotes are obtained from broker-dealers to estimate fair values. As significant inputs used to price corporate and municipal bonds are observable market inputs, fair values are included in the Level 2 fair value hierarchy. Equity securities - The fair value of equity securities is primarily priced by pricing services, reflecting the closing price quoted for the final trading day of the period. The common stock is carried at fair value using observable market pricing data and is included in the Level 1 fair value hierarchy. Any unrealized gains or losses on the investment is recorded in net income in the period in which they occur. Other investments — Includes unquoted investments comprised of the following investments: •Private equity investments: These are privately held equity investments in common and preferred stock. The fair values are estimated using quarterly financial statements and/or recent private market transactions and thus included under Level 3 of the fair value hierarchy due to unobservable market data used for valuation. •Private credit lending investments: These are privately held equity investments in common stock valued using the most recently available or quarterly NAV statements as provided by the external fund manager or third-party administrator and therefore measured using the NAV as a practical expedient. •Investment in limited partnerships: These investments are primarily comprised of investments in certain private equity funds. The fair value is estimated based on the most recently available NAV as advised by the external fund manager or third-party administrator. The fair values are therefore measured using the NAV as a practical expedient. •Other investments: These investments are comprised of investments in insurtech and other insurance focused companies. The fair value of these start-up insurance entities are determined using recent private market transactions where applicable and included in the Level 3 fair value hierarchy due to unobservable market data used for valuation. (b) Fair Value Hierarchy The Company’s estimates of fair value for financial assets and financial liabilities are based on the framework established in ASC 820. The framework is based on the inputs used in valuation and gives the highest priority to quoted prices in active markets and requires that observable inputs be used in the valuation methodology whenever available. In determining the level of the hierarchy in which the estimate is disclosed, the highest priority is given to unadjusted quoted prices in active trading markets and the lowest priority to unobservable inputs that reflect significant market assumptions. 5. Fair Value Measurements (continued) At March 31, 2021 and December 31, 2020, the Company classified its financial instruments measured at fair value on a recurring basis in the following valuation hierarchy:
The Company utilizes the Pricing Service to assist in determining the fair value of its investments; however, management is ultimately responsible for all fair values presented in the Company’s financial statements. This includes responsibility for monitoring the fair value process, ensuring objective and reliable valuation practices, and pricing of assets and liabilities and use of pricing sources. The Company analyzes and reviews the information and prices received from the Pricing Service to ensure that the prices provided represent a reasonable estimate of fair value. The Pricing Service was utilized to estimate fair value measurements for 99.3% and 99.1% of our fixed maturities at March 31, 2021 and December 31, 2020, respectively. The Pricing Service utilizes market quotations for fixed maturity securities that have quoted market prices in active markets. Since fixed maturities other than U.S. treasury bonds generally do not trade actively on a daily basis, the Pricing Service prepares estimates of fair value measurements using relevant market data, benchmark curves, sector groupings and matrix pricing and these have been classified as Level 2 within the fair value hierarchy. At March 31, 2021 and December 31, 2020, approximately 0.7% and 0.9%, respectively, of the Level 2 fixed maturities are valued using the market approach. At March 31, 2021, one security or $6,427 (2020 - two securities or $10,809) of fixed maturities classified as Level 2 were priced using a quotation from a broker and/or custodian as opposed to the Pricing Service due to lack of information available. At March 31, 2021 and December 31, 2020, the Company has not adjusted any pricing provided to it based on the review performed by its investment managers. During the three months ended March 31, 2021, the Company transferred its equity investment in an insurtech start-up company focused on technological advancement in the automobile insurance industry out of Level 3 within the fair value hierarchy and into Level 1 due to the recent completion of their initial public offering. There were no transfers to or from Level 3 during the three months ended March 31, 2020. 5. Fair Value Measurements (continued) (c) Level 3 Financial Instruments At March 31, 2021, the Company holds Level 3 financial instruments of $29,344 (December 31, 2020 - $26,094) which includes privately held equity investments in common and preferred stock. The fair value of these investments are estimated using quarterly unaudited financial statements or recent private market transactions, where applicable. Due to significant unobservable inputs in these valuations, the Company classifies their fair values as Level 3 within the fair value hierarchy. The following table provides a summary of quantitative information regarding the significant unobservable inputs used in determining the fair value of other investments measured at fair value on a recurring basis under the Level 3 classification at March 31, 2021:
The following table shows the reconciliation of the beginning and ending balances for other investments measured at fair value on a recurring basis using Level 3 inputs for the three months ended March 31, 2021 and 2020. The Company includes any related interest and dividend income in net investment income thus are excluded from the reconciliation in the table below:
(d) Financial Instruments Disclosed, But Not Carried, at Fair Value The fair value of financial instruments accounting guidance also applies to financial instruments disclosed, but not carried, at fair value, except for certain financial instruments related to insurance contracts. At March 31, 2021, the carrying values of cash and cash equivalents (including restricted amounts), accrued investment income, reinsurance balances receivable, loan to related party, liability for securities purchased and certain other assets and liabilities approximate fair values due to their inherent short duration. As these financial instruments are not actively traded, their fair values are classified as Level 2. The investments made by direct lending entities are carried at cost less impairment, if any, which approximates fair value. The fair value estimates of these investments are not based on observable market data and, as a result, are classified as Level 3. The fair values of the Senior Notes are based on indicative market pricing obtained from a third-party pricing service which uses observable market inputs, and therefore the fair values of these liabilities are classified as Level 2. The following table presents the respective carrying value and fair value for the Senior Notes as at March 31, 2021 and December 31, 2020:
|
Shareholders' Equity |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shareholders' Equity | Shareholders' Equity a)Common Shares At March 31, 2021, the aggregate authorized share capital of the Company is 150,000,000 shares from which 91,954,619 common shares were issued, of which 86,141,057 common shares are outstanding, and 18,600,000 preference shares were issued, all of which are outstanding. The remaining 39,445,381 shares are undesignated at March 31, 2021. Excluding the preference shares held by Maiden Reinsurance, a total of 9,157,912 preference shares are held by non-affiliates. b)Preference Shares On March 3, 2021, the Company's Board of Directors approved the repurchase, including the repurchase by Maiden Reinsurance in accordance with its investment guidelines, of up to $100,000 of the Company's preference shares from time to time at market prices in open market purchases or as may be privately negotiated. During March 2021, Maiden Reinsurance accepted for purchase primarily via private negotiation with certain security holders, (i) 2,561,636 shares of the Company's 8.25% Non-Cumulative Preference Shares Series A at an average price of $14.88 per share, (ii) 2,028,961 shares of the Company's 7.125% Non-Cumulative Preference Shares Series C at an average price of $14.65 per share, and (iii) 2,023,896 shares of the Company's 6.7% Non-Cumulative Preference Shares Series D at an average price of $14.60 per share for a total amount of $97,393. The acquisition by Maiden Reinsurance of these preference shares was made in compliance with the Company's investment guidelines previously approved by the Vermont DFR. These preference share purchases have resulted in a gain of $62,450 in the three months ended March 31, 2021. Please refer to "Note 14 — Subsequent Event" for further information on the repurchase of our preference shares. For further discussion on the components of Shareholders' Equity, please refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2020. c)Treasury Shares During the three months ended March 31, 2021, the Company repurchased a total of 799,548 common shares at an average price per share of $2.95 from employees, which represent withholding in respect of tax obligations on the vesting of both non-performance-based and discretionary performance-based restricted shares. There were no such repurchases during the three months ended March 31, 2020. On February 21, 2017, the Company's Board of Directors approved the repurchase of up to $100,000 of the Company's common shares from time to time at market prices. The Company has a remaining authorization of $74,245 for share repurchases at March 31, 2021 (December 31, 2020 - $74,245). No repurchases were made during the three months ended March 31, 2021 and 2020 under the common share repurchase plan. d)Accumulated Other Comprehensive Income The following tables set forth financial information regarding the changes in the balances of each component of AOCI:
|
Long-Term Debt |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-term Debt | Long-Term Debt Senior Notes At March 31, 2021 and December 31, 2020, both Maiden Holdings and its wholly owned subsidiary, Maiden NA, had outstanding publicly-traded senior notes which were issued in 2016 ("2016 Senior Notes") and 2013 ("2013 Senior Notes"), respectively (collectively "Senior Notes"). The 2013 Senior Notes issued by Maiden NA are fully and unconditionally guaranteed by Maiden Holdings. The Senior Notes are unsecured and unsubordinated obligations of the Company. The following tables detail the issuances of Senior Notes outstanding at March 31, 2021 and December 31, 2020:
The interest expense incurred on the Senior Notes for the three months ended March 31, 2021 was $4,777 (2020 - $4,777), of which $1,342 was accrued at both March 31, 2021 and December 31, 2020, respectively. The issuance costs related to the Senior Notes were capitalized and are being amortized over the effective life of the Senior Notes. The amortization expense for the three months ended March 31, 2021 was $54 (2020 - $54). Under the terms of the 2013 Senior Notes, the 2013 Senior Notes can be redeemed, in whole or in part, at Maiden NA's option at any time and from time to time, until maturity at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued but unpaid interest on the principal amount being redeemed to, but not including, the redemption date. Maiden NA is required to give at least thirty days and not more than sixty days notice prior to the redemption date.
|
Reinsurance |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance | Reinsurance The Company uses reinsurance and retrocessional agreements ("ceded reinsurance") to mitigate volatility, reduce its exposure to certain risks and provide capital support. Ceded reinsurance provides for the recovery of a portion of loss and LAE under certain circumstances without relieving the Company of its obligations to the policyholders. The Company remains liable to the extent that any of its reinsurers or retrocessionaires fails to meet their obligations. Loss and LAE incurred and premiums earned are reported after deduction for ceded reinsurance. In the event that one or more of our reinsurers or retrocessionaires are unable to meet their obligations under these agreements, the Company would not realize the full value of the reinsurance recoverable balances. The effect of ceded reinsurance on net premiums written and earned and on net loss and LAE for the three months ended March 31, 2021 and 2020 was as follows:
The Company's reinsurance recoverable on unpaid losses balance as at March 31, 2021 was $580,709 (December 31, 2020 - $592,571) presented in the Condensed Consolidated Balance Sheets. At March 31, 2021 and December 31, 2020, the Company had no valuation allowance against reinsurance recoverable on unpaid losses. On December 27, 2018, Cavello Bay Reinsurance Limited ("Cavello") and Maiden Reinsurance entered into a retrocession agreement pursuant to which certain assets and liabilities associated with the U.S. treaty reinsurance business held by Maiden Reinsurance were 100.0% retroceded to Cavello in exchange for a ceding commission. The reinsurance recoverable on unpaid losses due from Cavello under this retrocession agreement was $66,444 at March 31, 2021 (December 31, 2020 - $67,972). On July 31, 2019, Maiden Reinsurance and Cavello entered into a Loss Portfolio Transfer and Adverse Development Cover Agreement ("LPT/ADC Agreement") pursuant to which Cavello assumed the loss reserves as of December 31, 2018 associated with the AmTrust Quota Share in excess of a $2,178,535 retention up to $600,000, in exchange for a retrocession premium of $445,000. The $2,178,535 retention is subject to adjustment for paid losses subsequent to December 31, 2018. The LPT/ADC Agreement provides Maiden Reinsurance with $155,000 in adverse development cover over its carried AmTrust Quota Share loss reserves at December 31, 2018. The LPT/ADC Agreement meets the criteria for risk transfer and is thus accounted for as retroactive reinsurance. Cumulative ceded losses exceeding $445,000 are recognized as a deferred gain liability and amortized into income over the settlement period of the ceded reserves in proportion to cumulative losses collected over the estimated ultimate reinsurance recoverable. The amount of the deferral is recalculated each period based on loss payments and updated estimates. Consequently, cumulative adverse development subsequent to December 31, 2018 may result in significant losses from operations until periods when the deferred gain is recognized as a benefit to earnings. As of March 31, 2021, the reinsurance recoverable on unpaid losses under the retroactive reinsurance agreement was $510,096 while the deferred gain liability was $65,096 (December 31, 2020 - $519,941 and $74,941, respectively). Amortization of the deferred gain will not occur until paid losses have exceeded the minimum retention under the LPT/ADC Agreement, which is estimated to be in 2024. Cavello has provided collateral in the form of a letter of credit in the amount of $445,000 to AmTrust under the LPT/ADC Agreement and Cavello is subject to additional collateral funding requirements as explained in "Note 10. Related Party Transactions". Under the terms of the LPT/ADC Agreement, the covered losses associated with the Commutation and Release Agreement with AmTrust are eligible to be covered but recoverable only when such losses are paid or settled by AII or its affiliates, provided such losses and other related amounts shall not exceed $312,786. Cavello's parent company, Enstar, has credit ratings of BBB from both Standard & Poor's and Fitch Ratings at March 31, 2021.
|
Reserve for Loss and Loss Adjustment Expenses |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reserve for Loss and Loss Adjustment Expenses | Reserve for Loss and Loss Adjustment Expenses The Company uses both historical experience and industry-wide loss development factors to provide a reasonable basis for estimating future losses. In the future, certain events may be beyond the control of management, such as changes in law, judicial interpretations of law, and rates of inflation, which may favorably or unfavorably impact the ultimate settlement of the Company’s loss and LAE reserves. The anticipated effect of inflation is implicitly considered when estimating liabilities for loss and LAE. While anticipated changes in claim costs due to inflation are considered in estimating the ultimate claim costs, changes in the average severity of claims are caused by a number of factors that vary with the individual type of policy written. Ultimate losses are projected based on historical trends adjusted for implemented changes in underwriting standards, claims handling, policy provisions, and general economic trends. Those anticipated trends are monitored based on actual development and are modified if necessary. The reserving process begins with the collection and analysis of paid losses and incurred claims data for each of the Company's contracts. While reserves are mostly reviewed on a contract by contract basis, paid loss and incurred claims data is also aggregated into reserving segments. The segmental data is disaggregated by reserving class and further disaggregated by either accident year (i.e. the year in which the loss event occurred) or by underwriting year (i.e. the year in which the contract generating the premium and losses incepted). In cases where the Company uses underwriting year information, reserves are subsequently allocated to the respective accident year. The reserve for loss and LAE consists of:
The following table represents a reconciliation of our beginning and ending gross and net loss and LAE reserves:
Prior period development arises from changes to loss estimates recognized in the current year that relate to loss reserves established in previous calendar years. The favorable or unfavorable development reflects changes in management's best estimate of the ultimate losses under the relevant reinsurance policies after considerable review of changes in actuarial assessments. During the three months ended March 31, 2021, the Company recognized net favorable prior year loss development of $5,554 (2020 - favorable $533). In the Diversified Reinsurance segment, net adverse prior year loss development was $14 for the three months ended March 31, 2021 (2020 - favorable $533). Prior year loss development for the three months ended March 31, 2021 was due to adverse reserve development in European Capital Solutions and other runoff business. The favorable development for the three months ended March 31, 2020 was primarily due to favorable reserve development in German Auto Programs. 9. Reserve for Loss and Loss Adjustment Expenses (continued) In the AmTrust Reinsurance segment, the net favorable prior year loss development was $5,568 for the three months ended March 31, 2021 (2020 - $0). The net favorable prior year loss development for the three months ended March 31, 2021 was primarily due to favorable development in Workers Compensation partly offset by adverse development in Hospital Liability. Retroactive reinsurance adjustment of $9,845 represents the decrease in reinsurance recoverable on unpaid losses under the LPT/ADC Agreement with Cavello that was recognized in the three months ended March 31, 2021 (2020 - $0) in the reconciliation of our beginning and ending gross and net loss and LAE reserves presented above. It reflects the corresponding decrease in the deferred gain on retroactive reinsurance for favorable development on reserves covered under the LPT/ADC Agreement of $9,845 during the three months ended March 31, 2021. The deferred gain on retroactive reinsurance represents the cumulative adverse development under the AmTrust Quota Share covered under the LPT/ADC Agreement at March 31, 2021 and December 31, 2020. Amortization of the deferred gain will not occur until paid losses have exceeded the minimum retention under the LPT/ADC Agreement, which is estimated to be in 2024.
|
Related Party Transactions |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions | Related Party Transactions The Founding Shareholders of the Company were Michael Karfunkel, George Karfunkel and Barry Zyskind. Based on each individual's most recent public filing, Leah Karfunkel (wife of the late Michael Karfunkel) owns or controls approximately 7.8% of the Company's outstanding common shares and Barry Zyskind (the Company's non-executive chairman) owns or controls approximately 7.3% of the Company's outstanding common shares. George Karfunkel owns or controls less than 5.0% of the Company's outstanding common shares. Leah Karfunkel and George Karfunkel are directors of AmTrust, and Barry Zyskind is the chief executive officer and chairman of AmTrust. Leah Karfunkel, George Karfunkel and Barry Zyskind own or control approximately 53.2% of the ownership interests of Evergreen Parent LP, the ultimate parent of AmTrust. The following describes transactions that have transpired between the Company and AmTrust: AmTrust Quota Share Effective July 1, 2007, the Company and AmTrust entered into a master agreement, as amended ("Master Agreement"), by which they caused Maiden Reinsurance and AII to enter into the AmTrust Quota Share by which AII retroceded to Maiden Reinsurance an amount equal to 40% of the premium written by subsidiaries of AmTrust, net of the cost of unaffiliated inuring reinsurance and 40% of losses. The Master Agreement further provided that AII receive a ceding commission of 31% of ceded written premiums. On June 11, 2008, Maiden Reinsurance and AII amended the AmTrust Quota Share to add Retail Commercial Package Business to the Covered Business. AII receives a ceding commission of 34.375% on Retail Commercial Package Business. On July 1, 2016, the agreement was renewed through June 30, 2019. Effective July 1, 2018, the amount AEL ceded to Maiden Reinsurance was reduced to 20%. Effective July 1, 2013, for the Specialty Program portion of Covered Business only, AII was responsible for ultimate net loss otherwise recoverable from Maiden Reinsurance to the extent that the loss ratio to Maiden Reinsurance, which shall be determined on an inception to date basis from July 1, 2007 through the date of calculation, is between 81.5% and 95% ("Loss Corridor"). Above and below the Loss Corridor, Maiden Reinsurance continued to reinsure losses at its proportional 40% share of the AmTrust Quota Share. Effective July 31, 2019, the Loss Corridor was amended such that the maximum amount covered is $40,500, the amount calculated by Maiden Reinsurance for the Loss Corridor coverage as of March 31, 2019. Any development above this maximum amount will be subject to the coverage of the LPT/ADC Agreement. Effective January 1, 2019, Maiden Reinsurance and AII entered into a partial termination amendment ("Partial Termination Amendment") which amended the AmTrust Quota Share. The Partial Termination Amendment provided for the cut-off of the ongoing and unearned premium of AmTrust’s Small Commercial Business, comprising workers’ compensation, general liability, umbrella liability, professional liability (including cyber liability) insurance coverages, and U.S. Specialty Risk and Extended Warranty ("Terminated Business") as of December 31, 2018. Under the Partial Termination Amendment, the ceding commission payable by Maiden Reinsurance for its remaining in-force business immediately prior to January 1, 2019 increased by five percentage points with respect to in-force remaining business (excluding Terminated Business) and related unearned premium as of January 1, 2019. The Partial Termination Amendment resulted in Maiden Reinsurance returning $647,980 in unearned premium to AII, or $436,760 net of applicable ceding commission and brokerage as calculated during the second quarter of 2019. Subsequently, on January 30, 2019, Maiden Reinsurance and AII agreed to terminate the remaining business subject to the AmTrust Quota Share on a run-off basis effective as of January 1, 2019. Effective July 31, 2019, Maiden Reinsurance and AII entered into a Commutation and Release Agreement which provided for AII to assume all reserves ceded by AII to Maiden Reinsurance with respect to its proportional 40% share of the ultimate net loss under the AmTrust Quota Share related to the commuted business including: (a) all losses incurred in Accident Year 2017 and Accident Year 2018 under California workers' compensation policies and as defined in the AmTrust Quota Share ("Commuted California Business"); and (b) all losses incurred in Accident Year 2018 under New York workers' compensation policies ("Commuted New York Business"), and together with the Commuted California Business ("Commuted Business") in exchange for the release and full discharge of Maiden Reinsurance's obligations to AII with respect to the Commuted Business. The Commuted Business excludes any business classified by AII as Specialty Program or Specialty Risk business. 10. Related Party Transactions (continued) Maiden Reinsurance paid $312,786 ("Commutation Payment"), which is the sum of the net ceded reserves in the amount of $330,682 with respect to the Commuted Business as of December 31, 2018 less payments in the amount of $17,896 made by Maiden Reinsurance with respect to the Commuted Business from January 1, 2019 through July 31, 2019. The Commutation Payment was settled on August 12, 2019 and Maiden Reinsurance paid AII approximately $6,335 in interest related to the Commutation Payment premium, calculated at the rate of 3.30% per annum from January 1, 2019 through August 12, 2019. AII and Maiden Reinsurance also agreed that as of July 31, 2019, the AmTrust Quota Share was deemed amended as applicable so that the Commuted Business is no longer included as part of Covered Business under the AmTrust Quota Share. On January 30, 2019, in connection with the termination of the reinsurance agreement described above, the Company and AmTrust entered into a second amendment to the Master Agreement between the parties, originally entered into on July 3, 2007, to remove the provisions requiring AmTrust to reinsure business with the Company. European Hospital Liability Quota Share Effective April 1, 2011, Maiden Reinsurance entered into the European Hospital Liability Quota Share with AEL and AIU DAC. Pursuant to the terms of the European Hospital Liability Quota Share, Maiden Reinsurance assumed 40% of the premiums and losses related to policies classified as European Hospital Liability, including associated liability coverages and policies covering physician defense costs, written or renewed on or after April 1, 2011. The European Hospital Liability Quota Share also covers policies written or renewed on or before March 31, 2011, but only with respect to losses that occur, accrue or arise on or after April 1, 2011. The maximum limit of liability attaching shall be €5,000 (€10,000 effective January 1, 2012) or currency equivalent (on a 100% basis) per original claim for any one original policy. Maiden Reinsurance paid a ceding commission of 5% on contracts assumed under the European Hospital Liability Quota Share. Effective July 1, 2016, the European Hospital Liability Quota Share was amended such that Maiden Reinsurance assumes from AEL 32.5% of the premiums and losses of all policies written or renewed on or after July 1, 2016 until June 30, 2017 and 20% of all policies written or renewed on or after July 1, 2017. Thereafter, on January 30, 2019, Maiden Reinsurance, AEL and AIU DAC agreed to terminate the European Hospital Liability Quota Share on a run-off basis effective as of January 1, 2019. The table below shows the effect of both of these quota share arrangements with AmTrust on the Company's Condensed Consolidated Income Statements for the three months ended March 31, 2021 and 2020, respectively:
Collateral provided to AmTrust a) AmTrust Quota Share To provide AmTrust's U.S. insurance subsidiaries with credit for reinsurance on their statutory financial statements, AII, as the direct reinsurer of AmTrust's insurance subsidiaries, established trust accounts ("Trust Accounts") for their benefit. Maiden Reinsurance agreed to provide appropriate collateral to secure its proportional share under the AmTrust Quota Share of AII's obligations to the AmTrust subsidiaries to whom AII is required to provide collateral. This collateral can take the form of (a) assets loaned by Maiden Reinsurance to AII for deposit into the Trust Accounts, pursuant to a loan agreement between those parties, (b) assets transferred by Maiden Reinsurance for deposit into the Trust Accounts, or (c) a letter of credit obtained by Maiden Reinsurance and delivered to an AmTrust subsidiary on AII's behalf. Maiden Reinsurance may provide any or a combination of these forms of collateral, provided that the aggregate value thereof equals Maiden Reinsurance's proportionate share of its obligations under the AmTrust Quota Share. Maiden Reinsurance satisfied its collateral requirements under the AmTrust Quota Share with AII as follows: •by lending funds of $167,975 at March 31, 2021 and December 31, 2020 pursuant to a loan agreement entered into between those parties. Advances under the loan are secured by promissory notes. This loan was assigned by AII to AmTrust effective December 31, 2014 and is carried at cost. Interest is payable at a rate equivalent to the Federal Funds Effective Rate ("Fed Funds") plus 200 basis points per annum. Interest income on the loan was $860 for the three months ended March 31, 2021 (2020 - $1,365) and the effective yield was 2.0% for the period (2020 - 3.3%). •on January 30, 2019, in connection with the termination of the reinsurance agreements described above, the Company and AmTrust amended the Loan Agreement between Maiden Reinsurance, AmTrust and AII, originally entered into on November 16, 2007, by extending the maturity date to January 1, 2025 and specifies that due to the termination of the AmTrust Quota Share, no further loans or advances may be made pursuant to the Loan Agreement; 10. Related Party Transactions (continued) •effective December 1, 2008, the Company entered into a Reinsurer Trust Assets Collateral agreement to provide to AII sufficient collateral to secure its proportional share of AII's obligations to the U.S. AmTrust subsidiaries. The amount of the collateral at March 31, 2021 was $493,363 (December 31, 2020 - $666,879) and the accrued interest was $2,454 (December 31, 2020 - $3,048). Please refer to "Note 4. (e) Investments" for additional information; •on January 11, 2019, a portion of the existing trust accounts used for collateral on the AmTrust Quota Share were converted to a funds withheld arrangement. The Company transferred $575,000 to AmTrust as a funds withheld receivable which currently has an annual interest rate of 1.8%, subject to annual adjustment. The annual interest rate was 2.65% for the duration of 2020. At March 31, 2021, the funds withheld balance was $575,000 (December 31, 2020 - $575,000) and the accrued interest was $2,552 (December 31, 2020 - $3,845). The interest income on the funds withheld receivable was $2,552 for the three months ended March 31, 2021 (2020 - $3,800). Pursuant to the terms of the LPT/ADC Agreement, Maiden Reinsurance, Cavello and AmTrust and certain of its affiliated companies entered into a Master Collateral Agreement (“MCA”) to define and enable the operation of collateral provided under the AmTrust Quota Share. Under the MCA, Cavello provided letters of credit on behalf of Maiden Reinsurance to AmTrust in an amount representing Cavello’s obligations under the LPT/ADC Agreement. Because these letters of credit replaced other collateral previously provided directly by Maiden Reinsurance to AmTrust, the MCA coordinates the collateral protection that will be provided to AmTrust to ensure that no gaps in collateral funding occur by operation of the LPT/ADC Agreement and related MCA. As a result of entering into both the LPT/ADC Agreement and the MCA, certain post-termination endorsements (“PTEs”) to the AmTrust Quota Share between AII and Maiden Reinsurance were required. Effective July 31, 2019, the PTEs: i) enable the operation of both the LPT/ADC Agreement and MCA by making provision for certain forms of collateral, including letters of credit provided by Cavello on Maiden Reinsurance’s behalf, and further defines the permitted use and return of collateral; and ii) increase the required funding percentage for Maiden Reinsurance under the collateral arrangements between the parties to 105% of its obligations, subject to a minimum excess funding requirement of $54,000, as may be mutually amended by the parties from time to time. Under certain defined conditions, Maiden Reinsurance may be required to increase this funding percentage to 110%. Effective March 16, 2020, Maiden Reinsurance discontinued as a Bermuda company and completed its re-domestication to the State of Vermont. Bermuda is a Solvency II equivalent jurisdiction and the State of Vermont is not such a jurisdiction; therefore, the collateral provided under the respective agreements with AmTrust subsidiaries was strengthened to reflect the impact of the re-domestication concurrent with the date of Maiden Reinsurance’s re-domestication to Vermont. Maiden Reinsurance and AmTrust agreed to: 1) amend the AmTrust Quota Share pursuant to Post Termination Endorsement No. 2 effective March 16, 2020; and 2) amend the European Hospital Liability Quota Share pursuant to Post Termination Endorsement No. 1 effective March 16, 2020. Pursuant to the terms of Post Termination Endorsement No. 2 to the AmTrust Quota Share, Maiden Reinsurance strengthened the collateral protection provided by Maiden Reinsurance to AII by increasing the required funding percentage for Maiden Reinsurance under the collateral arrangements between the parties to 110% of its obligations, subject to a minimum excess funding requirement of $54,000, as may be mutually amended by the parties from time to time. Post Termination Endorsement No. 2 also sets forth conditions by which the funding percentage will be reduced and the sequence of how collateral will be utilized as obligations as defined under the AmTrust Quota Share are satisfied. Pursuant to the terms of Post Termination Endorsement No. 1 to the European Hospital Liability Quota Share, Maiden Reinsurance strengthened the collateral protection provided by Maiden Reinsurance to AEL and AIU DAC by increasing the required funding percentage for Maiden Reinsurance under the collateral arrangements between the parties to the greater of 120% of the Exposure (as defined therein) and the amount of security required to offset the increase in the Solvency Capital Requirement (“SCR”) that results from the changes in the SCR which arise out of Maiden Reinsurance's re-domestication as compared to the SCR calculation if Maiden Reinsurance had remained domesticated in a Solvency II equivalent jurisdiction with a solvency ratio above 100% and provided collateral equivalent to 100% of the Exposure. b) European Hospital Liability Quota Share Collateral has been provided to both AEL and AIU DAC under the European Hospital Liability Quota Share. For AEL, the amount of the collateral held in reinsurance trust accounts at March 31, 2021 was $304,635 (December 31, 2020 - $318,063) and the accrued interest was $2,270 (December 31, 2020 - $2,283). For AIU DAC, the Company utilizes funds withheld to satisfy its collateral requirements. At March 31, 2021, the amount of funds withheld was $29,106 (December 31, 2020 - $28,093) and the accrued interest was $36 (December 31, 2020 - $318). AIU DAC pays Maiden Reinsurance a fixed annual interest rate of 0.5% on the average daily funds withheld balance which is subject to annual adjustment. The interest income on the funds withheld receivable was $37 for the three months ended March 31, 2021 (2020 - $71). Brokerage Agreement Effective July 1, 2007, the Company entered into a reinsurance brokerage agreement with AII Reinsurance Broker Ltd. ("AIIB"), a wholly owned subsidiary of AmTrust. Pursuant to the brokerage agreement, AIIB provided brokerage services relating to the AmTrust Quota Share and the European Hospital Liability Quota Share for a fee equal to 1.25% of the premium assumed. AIIB was not the Company's exclusive broker. The brokerage agreement was terminated as of March 15, 2019. Maiden Reinsurance recorded $69 of reinsurance brokerage expense for the three months ended March 31, 2021 (2020 - $234) and deferred reinsurance brokerage of $1,434 at March 31, 2021 (December 31, 2020 - $1,534) as a result of this agreement. 10. Related Party Transactions (continued) Asset Management Agreement Effective July 1, 2007, the Company entered into an asset management agreement with AII Insurance Management Limited ("AIIM"), a wholly owned subsidiary of AmTrust, pursuant to which AIIM agreed to provide investment management services to the Company. Effective January 1, 2018, AIIM provides investment management services for a quarterly fee of 0.02125% of the average value of the account. The agreement may be terminated upon 30 days written notice by either party. The Company recorded $272 of investment management fees for the three months ended March 31, 2021 (2020 - $400) under this agreement. On September 9, 2020, Maiden Reinsurance, AmTrust and AIIM entered into a novation agreement, effective July 1, 2020, which provided for the novation of the asset management agreement, dated January 1, 2018 between Maiden Reinsurance and AIIM, and the release by Maiden Reinsurance of AIIM's obligations under the asset management agreement. The novation mandates that AmTrust is to be bound by the terms of the asset management agreement in place of AIIM and AmTrust agrees to perform any and all past, present and future obligations of AIIM under the asset management agreement. On November 13, 2020, Maiden LF, Maiden GF, AmTrust and AIIM entered into a novation agreement, effective July 1, 2020, which provided for the novation of the asset management agreement, dated January 1, 2018 between Maiden LF, Maiden GF and AIIM, and the release by Maiden LF and Maiden GF of AIIM's obligations under the asset management agreement. The novation mandates that AmTrust is to be bound by the terms of the asset management agreement in place of AIIM and AmTrust agrees to perform any and all past, present and future obligations of AIIM under the asset management agreement. Insurance Management Services Agreement Effective August 31, 2019, the Company entered into an agreement with Risk Services - Vermont, Inc. ("Risk Services"), an affiliate of AmTrust. Pursuant to the agreement, Risk Services agreed to provide insurance management services to the Company including regulatory compliance services in connection with the re-domestication, licensing and operation of Maiden Reinsurance in the State of Vermont. The initial term of the agreement is three years and will automatically renew for an additional three years until either party gives written notice of its intention to terminate this agreement at least three months prior to the commencement of the next applicable period. The fee for this agreement was an initial $100 retainer for re-domestication services paid in 2019 and $100 annually with reimbursement for reasonable out-of-pocket expenses incurred by Risk Services pursuant to the terms of the agreement. The Company recorded $25 of fees for the three months ended March 31, 2021 and 2020, respectively. 683 Capital Partners, LP (“683 Partners”) At March 31, 2021, 683 Partners and its affiliates own or control approximately 8.9% of the outstanding common shares of the Company. 683 Partners and its affiliates are not related parties as defined in ASC 850: Related Party Disclosures. In addition, 683 Partners own $369 of the Company's 2016 Senior Notes and $663 of the Company's 2013 Senior Notes. Limited Partnership Agreement with 683 Capital Management, LLC ("683 Capital") In July 2020, the Company and 683 Capital entered into a limited partnership agreement (“683 LP Agreement”) whereby 683 Capital will separately manage certain funds of Maiden Reinsurance at its discretion, subject to guidelines established by the parties. Under the 683 LP Agreement, Maiden Reinsurance will pay 683 Capital a management fee and subject to certain metrics agreed to by the parties, an incentive fee upon attainment of those metrics. Maiden Reinsurance may periodically and in its discretion increase the amount invested under the 683 LP Agreement, and subject to certain conditions, reduce the amount invested under the 683 LP Agreement. Hedge fund investments of $31,125 were managed by 683 Capital under this agreement at March 31, 2021.
|
Commitments and Contingencies |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | Commitments and Contingencies There are no material changes from the commitments, contingencies and concentrations previously disclosed in the Company’s Form 10-K for the year ended December 31, 2020. a)Concentrations of Credit Risk At March 31, 2021 and December 31, 2020, the Company’s assets where significant concentrations of credit risk may exist include investments, cash and cash equivalents, loan to related party, reinsurance recoverable on unpaid losses and funds withheld receivable. Please refer to "Note 8. Reinsurance" for additional information regarding the Company's credit risk exposure on its reinsurance counterparties including the impact of the LPT/ADC Agreement effective January 1, 2019. The Company requires its reinsurers to have adequate financial strength. The Company evaluates the financial condition of its reinsurers and monitors its concentration of credit risk on an ongoing basis. Provisions are made for amounts considered potentially uncollectible. Letters of credit are provided by its reinsurers for material amounts recoverable as discussed in "Note 8 — Reinsurance". The Company manages the concentration of credit risk in its investment portfolio through issuer and sector exposure limitations. The Company believes it bears minimal credit risk in its cash on deposit. The Company also monitors the credit risk related to the loan to related party and funds withheld receivable, within which the largest balances are due from AmTrust. AmTrust has a financial strength/credit rating of A- (Excellent) from A.M. Best at March 31, 2021. To mitigate credit risk, the Company generally has a contractual right of offset thereby allowing claims to be settled net of any premiums or loan receivable. The Company believes these balances as at March 31, 2021 will be fully collectible. 11. Commitments and Contingencies (continued) b)Operating Lease Commitments The Company leases office spaces, housing, office equipment and company vehicles under various operating leases expiring in various years through 2024. The Company entered into one new short-term subleasing arrangement through December 31, 2021 during the three months ended March 31, 2021. The Company's leases are all currently classified as operating leases and none of them have non-lease components. For operating leases that have an initial lease term of more than twelve months, and whose lease payments are above a certain threshold, the Company has recognized a lease liability and a right-of-use asset in the Company's Condensed Consolidated Balance Sheets at the present value of the remaining lease payments until expiration. As the lease contracts generally do not provide an implicit discount rate, the Company used the weighted-average discount rate of 10%, representing its secured incremental borrowing rate, in calculating the present value of the lease liability. The Company has made an accounting policy election not to include renewal, termination, or purchase options that are not reasonably certain of exercise when determining the term of the borrowing. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. The Company's weighted-average remaining lease term is approximately 1.6 years at March 31, 2021. At March 31, 2021, the Company's future lease obligations of $807 (December 31, 2020 - $1,638) was calculated based on the present value of future annual rental commitments excluding taxes, insurance and other operating costs for non-cancellable operating leases discounted using its secured incremental borrowing rate. This amount has been recognized on the Condensed Consolidated Balance Sheets as a lease liability of $807 within accrued expenses and other liabilities with an equivalent amount for the right-of-use asset presented as part of . Under Topic 842, Leases, the Company continues to recognize the related leasing expense on a straight-line basis over the lease term in the Condensed Consolidated Statements of Income. The Company's total lease expense for the three months ended March 31, 2021 was $242 (2020 - $410) recognized within net income consistent with the prior accounting treatment under Topic 840. The operating cash outflows from operating leases included in the measurement of the lease liability during the three months ended March 31, 2021 was $212 (2020 - $340). The Company also recorded $126 of sublease income for the three months ended March 31, 2021. At March 31, 2021, the scheduled maturity of the Company's operating lease liabilities are expected to be as follows:
c)Legal Proceedings Except as noted below, the Company is not a party to any material legal proceedings. From time to time, the Company is subject to routine legal proceedings, including arbitrations, arising in the ordinary course of business. These legal proceedings generally relate to claims asserted by or against the Company in the ordinary course of insurance or reinsurance operations. Based on the Company's opinion, the eventual outcome of these legal proceedings is not expected to have a material adverse effect on its financial condition or results of operations. In April 2009, the Company learned that Bentzion S. Turin, the former Chief Operating Officer, General Counsel and Secretary of Maiden Holdings and Maiden Reinsurance, sent a letter to the U.S. Department of Labor claiming that his employment with the Company was terminated in retaliation for corporate whistle-blowing in violation of the whistle-blower protection provisions of the Sarbanes-Oxley Act of 2002. Mr. Turin alleged that he was terminated for raising concerns regarding corporate governance with respect to the negotiation of the terms of the Trust Preferred Securities Offering. He seeks reinstatement as Chief Operating Officer, General Counsel and Secretary of Maiden Holdings and Maiden Reinsurance, back pay and legal fees incurred. On December 31, 2009, the U.S. Secretary of Labor found no reasonable cause for Mr. Turin’s claim and dismissed the complaint in its entirety. Mr. Turin objected to the Secretary's findings and requested a hearing before an administrative law judge in the U.S. Department of Labor. The Company moved to dismiss Mr. Turin's complaint, and its motion was granted by the Administrative Law Judge on June 30, 2011. On July 13, 2011, Mr. Turin filed a petition for review of the Administrative Law Judge's decision with the Administrative Review Board in the U.S. Department of Labor. On March 29, 2013, the Administrative Review Board reversed the dismissal of the complaint on procedural grounds, and remanded the case to the administrative law judge. The administrative hearing began in September 2014 and concluded in November 2018. The Company believes that it had good and sufficient reasons for terminating Mr. Turin's employment and that the claim is without merit. The Company will continue to vigorously defend itself against this claim. 11. Commitments and Contingencies (continued) A putative class action complaint was filed against Maiden Holdings, Arturo M. Raschbaum, Karen L. Schmitt, and John M. Marshaleck in the United States District Court for the District of New Jersey on February 11, 2019. On February 19, 2020, the Court appointed lead plaintiffs, and on May 1, 2020, lead plaintiffs filed an amended class action complaint (the “Amended Complaint”).The Amended Complaint asserts violations of Section 10(b) of the Exchange Act and Rule 10b-5 (and Section 20(a) for control person liability) arising in large part from allegations that Maiden failed to take adequate loss reserves in connection with reinsurance provided to AmTrust. Plaintiffs further claim that certain of Maiden Holdings’ representations concerning its business, underwriting and financial statements were rendered false by the allegedly inadequate loss reserves, that these misrepresentations inflated the price of Maiden Holdings' common stock, and that when the truth about the misrepresentations was revealed, the Company’s stock price fell, causing Plaintiffs to incur losses. On September 11, 2020, a motion to dismiss was filed on behalf of all Defendants; we cannot predict when the Court will issue a decision on the motion. We believe the claims are without merit and we intend to vigorously defend ourselves. It is possible that additional lawsuits will be filed against the Company, its subsidiaries and its respective officers due to the diminution in value of our securities as a result of our operating results and financial condition. It is currently uncertain as to the effect of such litigation on our business, operating results and financial condition.
|
Earnings per Common Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings per Common Share | Earnings per Common Share The following is a summary of the elements used in calculating basic and diluted earnings per common share:
(1)This represents the share in net income using the two-class method for holders of non-vested restricted shares issued to the Company's employees under the 2019 Omnibus Incentive Plan. (2)Please refer to "Note 13. Shareholders' Equity" and "Note 14. Share Compensation and Pension Plans" in the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 for the terms and conditions of securities that could potentially be dilutive in the future. For the three months ended March 31, 2021, there were 3,949 potentially dilutive securities.
|
Income Taxes |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company uses the estimated annual effective tax rate method. Certain items, including those deemed to be unusual, infrequent or that cannot be reliably estimated, are excluded from the estimated annual effective tax rate. In these cases, the actual tax expense or benefit is reported in the same period as the related item. Certain tax effects are also not reflected in the estimated annual effective tax rate, primarily certain changes in the realizability of deferred tax assets "(DTAs") and uncertain tax positions. Maiden NA files a consolidated federal income tax return for the Company’s U.S. based subsidiaries, including Maiden Reinsurance, which re-domesticated from Bermuda to Vermont on March 16, 2020 and, as a result, became subject to U.S. taxes. Maiden NA has net operating loss carry-forwards and other DTAs and deferred tax liabilities that are not presently recognized as a net DTA because a full valuation allowance is currently carried against them. On March 27, 2020, the U.S. enacted the Coronavirus Aid, Relief and Economic Security Act (the “CARES” Act) to mitigate the economic impacts of COVID-19. The Company believes that the provisions of the CARES Act will not have a material impact on its U.S. federal tax liabilities.
|
Subsequent Event |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Event | Subsequent EventOn May 6, 2021, the Company's Board of Directors approved the additional repurchase, including the repurchase by Maiden Reinsurance in accordance with its investment guidelines (as may be amended), of up to $50,000 of the Company's preference shares from time to time at market prices in open market purchases or as may be privately negotiated. |
Significant Accounting Policies (Policies) |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of Maiden Holdings, Ltd. ("Maiden Holdings") and its subsidiaries (the "Company" or "Maiden"). They have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X as promulgated by the U.S. Securities and Exchange Commission ("SEC"). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. All significant intercompany transactions and accounts have been eliminated. These interim unaudited Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim period and all such adjustments are of a normal recurring nature. The results of operations for the interim period are not necessarily indicative, if annualized, of those to be expected for the full year. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. These unaudited Condensed Consolidated Financial Statements, including these notes, should be read in conjunction with the Company's audited Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020. Certain prior year comparatives have been reclassified to conform to the current year presentation. The effect of these reclassifications had no impact on previously reported shareholders' equity or net income. As a result of a series of strategic actions the Company has taken in recent years as discussed below, we create shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets mostly in the insurance and related financial services industries where we can leverage our deep knowledge of those markets. We also provide a full range of legacy services to small insurance companies, particularly those in run-off or with blocks of reserves that are no longer core, working with clients to develop and implement finality solutions including acquiring entire companies. We expect our legacy solutions business to contribute to our active asset and capital management strategies. Short-term income protection business is written on a primary basis by our wholly owned subsidiaries Maiden Life Försäkrings AB ("Maiden LF") and Maiden General Försäkrings AB ("Maiden GF") in the Scandinavian and Northern European markets. Insurance support services are provided to Maiden LF and Maiden GF by our UK services company, Maiden Global Holdings Ltd. (“Maiden Global”) which is also a licensed intermediary in the United Kingdom. Maiden Global had previously operated internationally by providing branded auto and credit life insurance products through insurer partners, particularly those in the European Union ("EU") and other global markets. These products also produced reinsurance programs which were underwritten by our wholly owned subsidiary Maiden Reinsurance Ltd. (“Maiden Reinsurance”). The Company is not actively underwriting reinsurance business but has some historic reinsurance programs underwritten by Maiden Reinsurance which are in run-off. The Company continues to run-off the liabilities associated with AmTrust Financial Services, Inc. ("AmTrust") reinsurance agreements which were terminated in 2019 as discussed in "Note 10 - Related Party Transactions". We have a retroactive reinsurance agreement and a commutation agreement that further reduces our exposure to and limits the potential volatility related to these AmTrust liabilities
|
Recently Adopted Accounting Standards Updates and Recently Issued Accounting Standards Not Yet Adopted | Recently Adopted Accounting Standards Updates No new accounting standards have been recently adopted for the three months ended March 31, 2021. Recently Issued Accounting Standards Not Yet Adopted Accounting for Measurement of Credit Losses on Financial Instruments In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13 "Financial Instruments: Credit Losses (Topic 326)" replacing the "incurred loss" impairment methodology with an approach based on "expected losses" to estimate credit losses on certain types of financial instruments and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance requires financial assets to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the cost of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. ASU 2016-13 also modified the accounting for available-for-sale ("AFS") debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments: Credit Losses Available-for-Sale Debt Securities. Credit losses relating to AFS debt securities will be recorded through an allowance for credit losses rather than under the current other-than-temporarily impaired ("OTTI") methodology. In April 2019, the FASB issued ASU 2019-04 for targeted improvements related to ASU 2016-13 which clarify that an entity should include all expected recoveries in its estimate of the allowance for credit losses. In addition, for collateral dependent financial assets, the amendments mandate that an allowance for credit losses that is added to the amortized cost basis of the financial asset should not exceed amounts previously written off. It also clarifies FASB’s intent to include all reinsurance recoverables within the scope of Topic 944 to be within the scope of Subtopic 326-20, regardless of the measurement basis of those recoverables. The Company's reinsurance recoverable on unpaid losses is currently the most significant financial asset within the scope of ASU 2016-13. The guidance is effective for public business entities, excluding entities eligible to be smaller reporting companies ("SRCs") as defined by the SEC, for annual periods beginning after December 15, 2019, and interim periods therein. The guidance is effective for all other entities, including public entities eligible to be SRCs, for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. As of March 31, 2021, the Company qualified for SRC status, as determined on the last business day of its most recent second quarter, and is thus eligible to follow the reporting deadlines and effective dates applicable to SRCs. Therefore Topic 326 will not be effective until the 2023 fiscal year. The Company continues to evaluate the impact of this guidance on its results of operations, financial condition and liquidity.
|
Fair Value of Financial Instruments | Fair Values of Financial Instruments Fair Value Measurements — Accounting Standards Codification Topic 820, "Fair Value Measurements and Disclosures" ("ASC 820") defines fair value as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between open market participants at the measurement date. Additionally, ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy is broken down into three levels based on the reliability of inputs: •Level 1 — Valuations based on unadjusted quoted market prices for identical assets or liabilities that we have the ability to access. Because valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Examples of assets and liabilities utilizing Level 1 inputs include: U.S. Treasury bonds; •Level 2 — Valuations based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in inactive markets, or valuations based on models where the significant inputs are observable (e.g. interest rates, yield curves, prepayment speeds, default rates, loss severity, etc.) or can be corroborated by observable market data. Examples of assets and liabilities utilizing Level 2 inputs include: U.S. government-sponsored agency securities; non-U.S. government and supranational obligations; commercial mortgage-backed securities ("CMBS"); collateralized loan obligations ("CLO"); corporate and municipal bonds; and •Level 3 — Valuations based on models where significant inputs are not observable. The unobservable inputs reflect our own assumptions about assumptions that market participants would use developed on the basis of the best information available in the particular circumstances. Examples of assets and liabilities utilizing Level 3 inputs include: an investment in preference shares of a start-up insurance producer. The availability of observable inputs can vary and is affected by a wide variety of factors, including, for example, the type of financial instrument, whether the financial instrument is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires significantly more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in the Level 3 hierarchy. The Company uses prices and inputs that are current as at the measurement date. In periods of market dislocation, the observability of prices and inputs may be reduced for many instruments. This condition could cause an instrument to be reclassified between hierarchy levels. For investments that have quoted market prices in active markets, the Company uses the quoted market prices as fair value and includes these in the Level 1 hierarchy. The Company receives the quoted market prices from a third party nationally recognized provider ("the Pricing Service"). When quoted market prices are unavailable, the Company utilizes the Pricing Service to determine an estimate of fair value. The fair value estimates are included in the Level 2 hierarchy. The Company will challenge any prices for its investments which are considered not to be representative of fair value. 5. Fair Value Measurements (continued) If quoted market prices and an estimate from the Pricing Service are unavailable, the Company produces an estimate of fair value based on dealer quotations for recent activity in positions with the same or similar characteristics to that being valued. The Company determines whether the fair value estimate is in the Level 2 or Level 3 hierarchy depending on the level of observable inputs available when estimating the fair value. The Company bases its estimates of fair values for assets on the bid price as it represents what a third party market participant would be willing to pay in an orderly transaction. ASC 825, "Disclosure About Fair Value of Financial Instruments", requires all entities to disclose the fair value of their financial instruments for assets and liabilities recognized and not recognized in the balance sheet, for which it is practicable to estimate fair value. The following describes the valuation techniques used by the Company to determine the fair value of financial instruments that are measured at fair value on a recurring basis held at March 31, 2021 and December 31, 2020. U.S. government and U.S. agency — Bonds issued by the U.S. Treasury, the Federal Home Loan Bank, the Federal Home Loan Mortgage Corporation, Government National Mortgage Association, Federal National Mortgage Association and the Federal Farm Credit Banks Funding Corporation. The fair values of U.S. treasury bonds are based on quoted market prices in active markets, and are included in the Level 1 fair value hierarchy. We believe the market for U.S. treasury bonds is an actively traded market given the high level of daily trading volume. The fair values of U.S. agency bonds are determined using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of U.S. agency bonds are included in the Level 2 fair value hierarchy. Non-U.S. government and supranational bonds — These securities are generally priced by independent pricing services. The Pricing Service may use current market trades for securities with similar quality, maturity and coupon. If no such trades are available, the Pricing Service typically uses analytical models which may incorporate spreads, interest rate data and market/sector news. As the significant inputs used to price non-U.S. government and supranational bonds are observable market inputs, the fair values of non-U.S. government and supranational bonds are included in the Level 2 fair value hierarchy. Asset-backed securities — These securities comprise commercial mortgage-backed securities ("CMBS") and collateralized loan obligations ("CLO") originated by a variety of financial institutions that on acquisition are rated BBB-/Baa3 or higher. These securities are priced by independent pricing services and brokers. The pricing provider applies dealer quotes and other available trade information, prepayment speeds, yield curves and credit spreads to the valuation. As the significant inputs used to price the CMBS and CLO are observable market inputs, their fair values are included in the Level 2 fair value hierarchy. Corporate and municipal bonds — Bonds issued by corporations, U.S. state and municipality entities or agencies that on acquisition are rated BBB-/Baa3 or higher. These securities are generally priced by independent pricing services. The credit spreads are sourced from broker/dealers, trade prices and new issue market. Where pricing is unavailable from pricing services, custodian pricing or non-binding quotes are obtained from broker-dealers to estimate fair values. As significant inputs used to price corporate and municipal bonds are observable market inputs, fair values are included in the Level 2 fair value hierarchy. Equity securities - The fair value of equity securities is primarily priced by pricing services, reflecting the closing price quoted for the final trading day of the period. The common stock is carried at fair value using observable market pricing data and is included in the Level 1 fair value hierarchy. Any unrealized gains or losses on the investment is recorded in net income in the period in which they occur. Other investments — Includes unquoted investments comprised of the following investments: •Private equity investments: These are privately held equity investments in common and preferred stock. The fair values are estimated using quarterly financial statements and/or recent private market transactions and thus included under Level 3 of the fair value hierarchy due to unobservable market data used for valuation. •Private credit lending investments: These are privately held equity investments in common stock valued using the most recently available or quarterly NAV statements as provided by the external fund manager or third-party administrator and therefore measured using the NAV as a practical expedient. •Investment in limited partnerships: These investments are primarily comprised of investments in certain private equity funds. The fair value is estimated based on the most recently available NAV as advised by the external fund manager or third-party administrator. The fair values are therefore measured using the NAV as a practical expedient. •Other investments: These investments are comprised of investments in insurtech and other insurance focused companies. The fair value of these start-up insurance entities are determined using recent private market transactions where applicable and included in the Level 3 fair value hierarchy due to unobservable market data used for valuation.
|
Segment Information (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Underwriting results and reconciliation from reportable segments and other's category net income (loss) to consolidated | The following tables summarize the underwriting results of our reportable segments and the reconciliation of our reportable segments' underwriting results to consolidated net income from operations:
3. Segment Information (continued)
(1)Calculated by dividing net loss and LAE by the sum of net premiums earned and other insurance revenue. (2)Calculated by dividing commission and other acquisition expenses by the sum of net premiums earned and other insurance revenue. (3)Calculated by dividing general and administrative expenses by the sum of net premiums earned and other insurance revenue. (4)Calculated by adding together the commission and other acquisition expense ratio and general and administrative expense ratio. (5)Calculated by adding together net loss and LAE ratio and the expense ratio.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of assets from reportable segments to consolidated | The following tables summarize the financial position of the Company's reportable segments including the reconciliation to the Company's consolidated total assets at March 31, 2021 and December 31, 2020:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net premiums by major line of business | The following table sets forth financial information relating to net premiums written by major line of business and reportable segment for the three months ended March 31, 2021 and 2020:
The following table sets forth financial information relating to net premiums earned by major line of business and reportable segment for the three months ended March 31, 2021 and 2020:
|
Investments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amortized cost, gross unrealized gains and losses and fair value on fixed maturities | The amortized cost, gross unrealized gains and losses, and fair value of fixed maturities at March 31, 2021 and December 31, 2020 are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contractual maturities of fixed maturities | The contractual maturities of our fixed maturities are shown below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of fixed maturities in an unrealized loss position and the aggregate fair value and gross unrealized loss by length of time the securities have continuously been in an unrealized loss position | The following tables summarize fixed maturities in an unrealized loss position and the aggregate fair value and gross unrealized loss by length of time the security has continuously been in an unrealized loss position:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of the credit ratings of fixed maturities | The following tables summarize the credit ratings of our fixed maturities as at March 31, 2021 and December 31, 2020:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Portfolio of other investments | The table shows the composition of the Company's other investments as at March 31, 2021 and December 31, 2020:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remaining unfunded commitments on other investments | The Company's remaining unfunded commitments on other investments as at March 31, 2021 and December 31, 2020 were:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity method investments | The table below shows the carrying value of the Company's equity method investments as at March 31, 2021 and December 31, 2020:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net investment income | Net investment income was derived from the following sources for the three months ended March 31, 2021 and 2020:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Analysis of realized and unrealized gains (losses) on investment | Realized gains or losses on the sale of investments are determined on the basis of the first in first out cost method. The following tables show the net realized gains (losses) on investment included in the Condensed Consolidated Statements of Income:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net unrealized gains on fixed maturity investments | Net unrealized gains on investments was as follows at March 31, 2021 and December 31, 2020, respectively:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value of restricted assets | The fair values of these restricted assets were as follows at March 31, 2021 and December 31, 2020:
|
Fair Value of Financial Instruments (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value hierarchy of financial assets and financial liabilities measured on a recurring basis | At March 31, 2021 and December 31, 2020, the Company classified its financial instruments measured at fair value on a recurring basis in the following valuation hierarchy:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant unobservable inputs for determining fair value of other investments | The following table provides a summary of quantitative information regarding the significant unobservable inputs used in determining the fair value of other investments measured at fair value on a recurring basis under the Level 3 classification at March 31, 2021:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of other investments measured at fair value on a recurring basis using Level 3 inputs | The following table shows the reconciliation of the beginning and ending balances for other investments measured at fair value on a recurring basis using Level 3 inputs for the three months ended March 31, 2021 and 2020. The Company includes any related interest and dividend income in net investment income thus are excluded from the reconciliation in the table below:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carrying values and fair values of financial instruments not measured at fair value | The following table presents the respective carrying value and fair value for the Senior Notes as at March 31, 2021 and December 31, 2020:
|
Shareholders' Equity (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of accumulated other comprehensive income (loss) | The following tables set forth financial information regarding the changes in the balances of each component of AOCI:
|
Long-Term Debt (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of outstanding senior notes issuances | The following tables detail the issuances of Senior Notes outstanding at March 31, 2021 and December 31, 2020:
|
Reinsurance (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of effects of reinsurance on premiums written and earned and on net loss and LAE | The effect of ceded reinsurance on net premiums written and earned and on net loss and LAE for the three months ended March 31, 2021 and 2020 was as follows:
|
Reserve for Loss and Loss Adjustment Expenses (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of liability for unpaid claims and claims adjustment expense | The reserve for loss and LAE consists of:
The following table represents a reconciliation of our beginning and ending gross and net loss and LAE reserves:
|
Related Party Transactions (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of quota share arrangements with AmTrust | The table below shows the effect of both of these quota share arrangements with AmTrust on the Company's Condensed Consolidated Income Statements for the three months ended March 31, 2021 and 2020, respectively:
|
Commitments and Contingencies (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||
Scheduled maturity of operating lease liabilities | At March 31, 2021, the scheduled maturity of the Company's operating lease liabilities are expected to be as follows:
|
Earnings per Common Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of elements used in calculating basic and diluted earnings per common share | The following is a summary of the elements used in calculating basic and diluted earnings per common share:
(1)This represents the share in net income using the two-class method for holders of non-vested restricted shares issued to the Company's employees under the 2019 Omnibus Incentive Plan. (2)Please refer to "Note 13. Shareholders' Equity" and "Note 14. Share Compensation and Pension Plans" in the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 for the terms and conditions of securities that could potentially be dilutive in the future. For the three months ended March 31, 2021, there were 3,949 potentially dilutive securities.
|
Basis of Presentation (Details) - Maiden Reinsurance North America, Inc. |
Mar. 16, 2020 |
---|---|
Subsidiary or Equity Method Investee [Line Items] | |
Ownership capital contributed | 65.00% |
Maiden Holdings North America, Ltd. | |
Subsidiary or Equity Method Investee [Line Items] | |
Ownership percentage | 100.00% |
Investments - Other Investments (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Schedule of Investments [Line Items] | ||
Carrying value | $ 37,684 | $ 30,439 |
% of Total | 50.80% | 45.40% |
Other investments | $ 74,217 | $ 67,010 |
% of Total | 100.00% | 100.00% |
Private equity investments | ||
Schedule of Investments [Line Items] | ||
Carrying value | $ 27,544 | $ 23,294 |
% of Total | 37.10% | 34.80% |
Private credit lending investments | ||
Schedule of Investments [Line Items] | ||
Carrying value | $ 5,109 | $ 1,301 |
% of Total | 6.90% | 1.90% |
Investment in limited partnerships | ||
Schedule of Investments [Line Items] | ||
Carrying value | $ 3,231 | $ 3,044 |
% of Total | 4.40% | 4.50% |
Other investments | ||
Schedule of Investments [Line Items] | ||
Carrying value | $ 1,800 | $ 2,800 |
% of Total | 2.40% | 4.20% |
Investments in direct lending entities | ||
Schedule of Investments [Line Items] | ||
Other investments | $ 36,533 | $ 36,571 |
% of Total | 49.20% | 54.60% |
Investments - Remaining Unfunded Commitments on Other Investments (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value | $ 60,104 | $ 63,313 |
% of Total | 100.00% | 100.00% |
Private equity investments | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value | $ 10,076 | $ 9,580 |
% of Total | 16.80% | 15.20% |
Private credit lending investments | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value | $ 29,863 | $ 33,584 |
% of Total | 49.70% | 53.00% |
Investments in direct lending entities | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value | $ 19,823 | $ 19,823 |
% of Total | 33.00% | 31.30% |
Investment in limited partnerships | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value | $ 342 | $ 326 |
% of Total | 0.50% | 0.50% |
Investments - Equity Method Investments (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Schedule of Equity Method Investments [Line Items] | ||
Remaining unfunded commitments on equity method investments | $ 60,104 | $ 63,313 |
Carrying Value | $ 40,183 | $ 39,886 |
% of Total | 100.00% | 100.00% |
Hedge fund investments | ||
Schedule of Equity Method Investments [Line Items] | ||
Carrying Value | $ 31,125 | $ 29,435 |
% of Total | 77.50% | 73.80% |
Investment in limited partnerships | ||
Schedule of Equity Method Investments [Line Items] | ||
Remaining unfunded commitments on equity method investments | $ 342 | $ 326 |
Carrying Value | $ 9,058 | $ 10,451 |
% of Total | 22.50% | 26.20% |
Investments - Net Investment Income (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Schedule of Investments [Line Items] | ||
Investment income | $ 10,185 | $ 18,365 |
Investment expenses | (344) | (401) |
Net investment income | 9,841 | 17,964 |
Fixed maturities | ||
Schedule of Investments [Line Items] | ||
Investment income | 6,691 | 12,651 |
Income on funds withheld | ||
Schedule of Investments [Line Items] | ||
Investment income | 2,505 | 3,853 |
Interest income from loan to related party | ||
Schedule of Investments [Line Items] | ||
Investment income | 860 | 1,365 |
Cash and cash equivalents and other investments | ||
Schedule of Investments [Line Items] | ||
Investment income | $ 129 | $ 496 |
Investments - Restricted Cash and Cash Equivalents and Investments (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
Mar. 31, 2020 |
---|---|---|---|
Restricted Cash and Investments Items [Line Items] | |||
Restricted cash | $ 53,038 | $ 61,786 | $ 117,903 |
Restricted investments | 838,641 | 1,018,269 | |
Restricted cash and investments | 891,679 | 1,080,055 | |
Third Party Agreements | |||
Restricted Cash and Investments Items [Line Items] | |||
Restricted cash | 20,476 | 20,547 | |
Restricted investments | 62,043 | 63,281 | |
Amortized cost | 62,041 | 63,253 | |
Related Party Agreements | |||
Restricted Cash and Investments Items [Line Items] | |||
Restricted cash | 32,562 | 41,239 | |
Restricted investments | 766,412 | 954,988 | |
Amortized cost | 744,273 | 913,466 | |
Related Party Agreements, Liability For Investments Purchased | |||
Restricted Cash and Investments Items [Line Items] | |||
Restricted investments | $ 10,186 | $ 0 |
Fair Value of Financial Instruments - Reconciliation of Other Investments Measured at Fair Value (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance - January 1 | $ 26,094 | $ 1,800 |
Purchases | 4,250 | 0 |
Transfers out of Level 3 | (1,000) | 0 |
Total Level 3 investments - end of period | $ 29,344 | $ 1,800 |
Long-Term Debt - Schedule of Outstanding Senior Notes Issuances (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt Instrument [Line Items] | ||
Principal amount | $ 262,500 | $ 262,500 |
Less: unamortized issuance costs | 7,320 | 7,374 |
Senior notes, net | 255,180 | 255,126 |
Senior Notes | ||
Debt Instrument [Line Items] | ||
Principal amount | 262,500 | 262,500 |
Less: unamortized issuance costs | 7,320 | 7,374 |
Senior notes, net | 255,180 | 255,126 |
Senior Notes | 2016 Senior Notes | ||
Debt Instrument [Line Items] | ||
Principal amount | 110,000 | 110,000 |
Less: unamortized issuance costs | 3,503 | 3,516 |
Senior notes, net | 106,497 | 106,484 |
Original debt issuance costs | $ 3,715 | |
Coupon rate | 6.625% | |
Effective interest rate | 7.07% | |
Senior Notes | 2013 Senior Notes | ||
Debt Instrument [Line Items] | ||
Principal amount | $ 152,500 | 152,500 |
Less: unamortized issuance costs | 3,817 | 3,858 |
Senior notes, net | 148,683 | $ 148,642 |
Original debt issuance costs | $ 5,054 | |
Coupon rate | 7.75% | |
Effective interest rate | 8.04% |
Long-Term Debt - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Dec. 31, 2020 |
|
Debt Instrument [Line Items] | |||
Interest expense | $ 4,831 | $ 4,831 | |
Senior Notes | |||
Debt Instrument [Line Items] | |||
Interest expense | 4,777 | 4,777 | |
Accrued interest | 1,342 | $ 1,342 | |
Amortization expense, debt issuance costs | $ 54 | $ 54 | |
2013 Senior Notes | Senior Notes | |||
Debt Instrument [Line Items] | |||
Redemption price, percentage | 100.00% | ||
Minimum | 2013 Senior Notes | Senior Notes | |||
Debt Instrument [Line Items] | |||
Prior notice to be given before redemption date | 30 days | ||
Maximum | 2013 Senior Notes | Senior Notes | |||
Debt Instrument [Line Items] | |||
Prior notice to be given before redemption date | 60 days |
Reinsurance - Effects of Reinsurance on Premiums Written and Earned and on Net Loss and LAE (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Premiums written | ||
Direct | $ 5,003 | $ 5,193 |
Assumed | (7,393) | 6,541 |
Ceded | (306) | (1,362) |
Net | (2,696) | 10,372 |
Premiums earned | ||
Direct | 5,854 | 4,761 |
Assumed | 6,944 | 27,453 |
Ceded | (1,034) | (999) |
Net premiums earned | 11,764 | 31,215 |
Loss and LAE | ||
Gross loss and LAE | 2,525 | 20,994 |
Loss and LAE ceded | (166) | 92 |
Net loss and loss adjustment expenses | $ 2,359 | $ 21,086 |
Related Party Transactions - Schedule of AmTrust Quota Share Arrangement (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Related Party Transaction [Line Items] | ||
Total | $ 11,764 | $ 31,215 |
Net loss and LAE | (2,359) | (21,086) |
Commission and other acquisition expenses | (5,942) | (11,973) |
Quota Share Reinsurance Agreements | AmTrust Financial Services, Inc. | ||
Related Party Transaction [Line Items] | ||
Gross and net premiums written | (2,462) | 0 |
Total | 5,524 | 18,684 |
Net loss and LAE | (944) | (14,045) |
Commission and other acquisition expenses | $ (2,187) | $ (6,994) |
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Dec. 31, 2020 |
|
Commitments and Contingencies Disclosure [Abstract] | |||
Operating lease, weighted average discount rate | 10.00% | ||
Operating lease, weighted average remaining lease term | 1 year 7 months 6 days | ||
Total discounted operating lease liabilities | $ 807 | $ 1,638 | |
Operating Lease, Liability, Statement of Financial Position [Extensible List] | Accrued expenses and other liabilities (includes $24,592 and $35,719 from related parties in 2021 and 2020, respectively) | Accrued expenses and other liabilities (includes $24,592 and $35,719 from related parties in 2021 and 2020, respectively) | |
Operating lease, right-of-use asset | $ 807 | ||
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | Other assets | ||
Lease cost | $ 242 | $ 410 | |
Operating cash outflows from operating leases | 212 | $ 340 | |
Sublease income | $ 126 |
Commitments and Contingencies - Scheduled Maturity of Operating Lease Liabilities Under Topic 842 (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Commitments and Contingencies Disclosure [Abstract] | ||
2021 | $ 636 | |
2022 | 96 | |
2023 | 96 | |
2024 | 48 | |
Discount for present value | (69) | |
Total discounted operating lease liabilities | $ 807 | $ 1,638 |
Earnings per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Numerator: | ||
Net income | $ 9,286 | $ 20,861 |
Gain from repurchase of preference shares | 62,450 | 0 |
Amount allocated to participating common shareholders | (1,133) | (247) |
Net income available to Maiden common shareholders, basic | 70,603 | 20,614 |
Net income available to Maiden common shareholders, diluted | $ 70,603 | $ 20,614 |
Denominator: | ||
Weighted average number of common shares - basic (in shares) | 85,132,939 | 83,256,223 |
Potentially dilutive securities: | ||
Share options and restricted share units (in shares) | 3,949 | 0 |
Adjusted weighted average number of common shares - diluted (in shares) | 85,136,888 | 83,256,223 |
Basic earnings per share attributable to common shareholders (in dollars per share) | $ 0.83 | $ 0.25 |
Diluted earnings per share attributable to common shareholders (in dollars per share) | $ 0.83 | $ 0.25 |
Subsequent Event (Details) - USD ($) |
May 06, 2021 |
Mar. 03, 2021 |
Feb. 21, 2017 |
---|---|---|---|
Subsequent Event [Line Items] | |||
Stock repurchased, authorized amount (up to) | $ 100,000,000 | ||
Preferred Stock | |||
Subsequent Event [Line Items] | |||
Stock repurchased, authorized amount (up to) | $ 100,000,000 | ||
Subsequent Event | Preferred Stock | |||
Subsequent Event [Line Items] | |||
Stock repurchased, authorized amount (up to) | $ 50,000,000 |
4_J\7_:5%_=(WNPR:C<3UHETY^S^,:F^
M%VNY56*A( M4LY$."FK#*K@::BID25AGEM- ^DH9Y633[.E[M0GQ
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M)IXV0@?:6#?(YDE],M@*\3',*5M"QSZ/W@4:FUK4&J(>88,
M^-D2PD5*"YIC0NP)-M 1WH0[MI8F/BX!N73&E@?PS
Y CA4J[(2O;*NYK^6Z+6+^'*3*Q-RB9W+N&*'"(:'W6?$
M33$F6> %DFV4OH?HN0GCI MJN,N K[LE8-2I"5^GJ&HNU8%ZX \=S3Z7L6_B
MX3YEWI?6'1W&AMB9N0+%_/6<[;?*MAYGN86 G'%+!%E2.F9^&6N^."^_>;9
M?/;T!R8NQ!IACRAVA*+(TL:>]QO[:>.$;\_S?9SN;,K/A7Y7[?[OD=_9^?. CVXS<$44]$&V
M9Q2T7]XF\.WM0V%OW[I -S=H6YH?#/L@HG..C[TG'*9!*JS).P#O(4&0J?Z8
M^U[8'AR*],29I@&=5]G@Q(D3F!]S7[D?Y_:=4AC;8[,]VD4IW^U ^.EP&K2O
MH&[PW1T&NP>[OOX=;WQ.18R6_-&8.H6V,O;+ZO!T^"Y]8C_'WDRW'[4!M"4=
MG JU@*@[2:*1T/9#L;TQ]9H_SLYJ8^J2+U=*XEQ'$R+Z2E";_H86&+[6O_@?
M4$L#!!0 ( *: JE)9R]>M$Q, ' Y 9 >&PO=V]R:W-H965T!T-SL8Z71EC''RDP
M=FEW@0AA0BZT'3AN 7&H>\$&'Z& J&^.[NQ01ID/MET0GBEF%GN-[@1."
M$8H%<^0TR@U;4+6<&0[>;-41)X?SMJOFOA8S@CA3<3N:NLX?$(L6"QC'0C7K
M4RO,Y#S?MK1KA10DE9ZXRN^D0&06B@"&Z!J$RXIM"@EC@P'-K"J7.6&<%N"A
M6]%7]"\@V,%0UAC@7%[1>M/#.'.[;Z.6T?V _Q'#FUJ*!YDKHL@Q&M*,'!=J
MQ$/H>$'$(_-%AYWN!G
*^X8)/?@2"QI9S)
Z 3
M#D:KO00M+(Y:$VA+4^W FW+K"('>7*XMLU_"8;9;H2G^;)4NU[#JT8JG7V
M>F6("U+C^/#G%\GL/!-0>Z84RNT&77"^+(][_8@7I'/+(>L"K(6>=>4_%A
M4UOG]VIK0QD&% &-L!:&=81]7A80)\)1IBK-T">"<*KMSKF0%6#FQA/G[+M!
MQ\8^=$$9'@""4W"C0+8TSE> RA@DTT)WPL"QLZ& 2LNB*V*IU&FUA?A4@$G]
M+1V:=W2(H]&![I>D$+ GF $7U ?8.6&:[<\@UUU>53M8 @X%:3 >3FA+3,=
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MF-L>[
!?B;] ;MX11WT>*][+TEID$3R.U?8U.
MXGOZ^\2_1U)SP70* [TON SB&SQO0/H#MX4@A,1>S(+*5#F0,W3\>6\G,"KI
M9U%(D/['T( 4-L7>I)1'F7M=S>*/'&77.K.<
KM%(/O'EBX<@:5TLZ1)-9K(]<"EHG*;;11_Y8963Y"J2B5$SGIE=\)
MN%(4CZ0L14D8A*'_J_=:6AF]I=U&0< B"A;)))A&"TIK%9H].PE496TELX!1
MZ^WS:1!-HB!,9@?;60?4!>M$D:EB'1!^*9H'TT8RJLH*B$4JCPH0>?XDY !K
M2)]AD9%!
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MJD T*21)M[SPK&OV(PT$%^MZ9N#E4N0<@+Y>2 $S]B6$[UQ\NOKXSM<
^)=K.$9Z".)"9' YD-K6&
M#_QU4RGZ'%4 ;/M!N_X-6VJ3'9< I9%M?ZIW/YX$LR3NJ(>7#5;WQL_V+3W[
MV
G<#C8BN?1:#:&DF]U= ,SG<-APP7\/(SFR,A7 Z[9U4VG.(HG
MBV@(XP.O-.#JM-LDC23?9$8735]'40J5-PPXWG6)7BGY>QA\?$5M.] /)L&]
MS>:F^@$%MDJ